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INTRODUCTION 
Extensive investigations have been conducted recently on 
eicosanoids, known more commonly as prostaglandins (PG). Prior to the 
discovery of two labile eicosanoids, prostacyclin (PGIg) and thromboxane 
(TXAg), most investigators examined PG of the E series, such as PGE^ and 
PGEg. More recently, the physiological effects of PGIg and TXA^ on the 
vascular endothelium and platelets have been examined in relationship to 
diabetes and cardiovascular disease (1). The majority of these 
investigations, however, have been in vitro studies. 
Eicosanoids are a family of compounds derived from the 20-carbon 
polyunsaturated fatty acids (2). They are believed to be synthesized in 
every tissue. Eicosanoid family members exhibit a wide variety of 
physiological effects. In many cases, their effects on tissues are 
antagonistic (3, 4). For example, PGI^ synthesis is localized mainly in 
the vascular endothelium. PGIg inhibits platelet aggregation (similar 
to PGEg) and relaxes the vascular smooth muscle (similar to PGEg). In 
contrast, TXAg synthesis occurs primarily in the platelets. TXAg 
promotes platelet aggregation (similar to PGEg) and constricts the 
smooth muscle. Platelet aggregation augments PGEg and PGE^ syntheses. 
Results from several investigations (5-9) imply that a delicate 
balance between the eicosanoid levels must be maintained in order to 
prevent the vascular complications associated with diabetes and 
cardiovascular disease. Current research results suggests that these 
pathological conditions are accompanied by decreased PGIg production 
and/or increased TXA^ synthesis (5-8). Whether these changes are a 
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primary action or a secondary effect of these disease states are 
unknown. It has been suggested that high circulating glucose 
concentrations contribute to the eicosanoid imbalances (9). 
Relationships between eicosanoid production and glucose concentrations 
in a human population free of microvascular complications, however, have 
not been examined. In addition, a relationship between excessive PG 
production and obesity has been suggested based on in vitro studies 
(10). It is not known, however, whether eicosanoid concentrations are 
related to body weight status of humans. 
Relationships between eicosanoid concentrations in body fluids and 
various physiological conditions in humans are of recent interest. 
Except for PGIg, virtually no information is available on plasma 
eicosanoid concentrations. Most of the information has been obtained on 
serum eicosanoid concentrations, mainly TXAg. The significance of 
plasma eicosanoid concentrations and their relationships to serum 
eicosanoid concentrations in humans is unknown. 
A standardized procedure for the evaluation of eicosanoids has not 
been established. Recently, Sullivan and Mathias (11) have suggested 
that the nutritional state [i.e., collection of samples during a fasting 
period (fasted) or a postprandial state (fed)] affects eicosanoid 
concentrations during various dietary treatments in rats. Whether 
eicosanoid concentrations in fasted blood samples are different from 
that in fed samples in humans has not been verified. 
The main objective of the present study was to examine eicosanoid, 
insulin, and glucose concentrations in a group of overweight and obese 
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young women. These females volunteered to participate in a Body Weight 
Management Program which was introduced into the Iowa State University 
(ISU) community by the present investigator. This program from 
September, 1982 to April, 1983 emphasized a nutritionally sensible 
lifestyle to lose body weight and maintain weight loss. During the 
program, the participants continued to live in the university residence 
halls; they ate their meals in their dining halls. The developmental 
procedures and the evaluation of the Body Weight Management Program are 
presented in the Appendixes. Financial support for this investigation 
was provided by the ISU Agriculture and Home Economics Experiment 
Station, Project No. 2567, entitled Metabolic Characteristics and Body 
Composition of Women. 
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LITERATURE REVIEW 
Eicosanoid Metabolism 
During the last 25 years, no group of compounds has captured as 
much attention from the scientific community as the eicosanoid family. 
The 1982 Nobel Prize was awarded to Sune Bergstrom and Bengt Samuelsson 
from Sweden and John Vane from Great Britain for their contributions to 
eicosanoid research (12). Since their discovery, these labile members 
of the arachidonic acid cascade have been studied in relation to a wide 
variety of clinical situations (3). Most recently, eicosanoids have 
been linked to the developmental and clinical expressions of 
atherosclerosis and diabetes mellitus. 
Enzymatic oxidation of arachidonic acid leads to the group of 
labile compounds known collectively as eicosanoids (13). The term 
eicosanoid applies to the 20-carbon polyunsaturated fatty acid 
derivatives (Figure 1). This multifunctional family includes 
prostaglandins (PG) such as PGE^ and PGEg, prostacyclin (PGIg), 
thromboxane-A2 (TXA^), and leukotrienes. The term prostaglandin is used 
traditionally to refer to all eicosanoids but it actually applies only 
to those compounds with a prostanoic acid skeleton such as PGE^ and PGEg 
(2). This review focuses on specific eicosanoids formed by the 
cyclooxygenase pathway: PG, PGI^, and TXA^. The products of the 
lipoxygenase pathway, the leukotrienes, are excluded from this review. 
The typical PG molecule consists of the prostanoid acid skeleton, a 
five membered ring structure with two side chains (Figure 1). Specific 
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chemical substitutions on the cyclopentane ring are indicated by letter 
designations such as E for PGE. The number of double bonds on the PG 
molecule side chains is denoted by subscripts, such as 1 and 2. 
Many excellent reviews on eicosanoid metabolism have been published 
during the last few years (1, 2, 14). A review of eicosanoid metabolism 
is essential before integrating their functions into physiological 
situations. In contrast to the conflicting reports of the physiological 
effects of the eicosanoid family members, the metabolism is quite well-
defined. 
Eicosanoids are extremely potent, ubiquitous compounds synthesized 
from 20-carbon polyunsaturated fatty acids (2). The essential fatty 
acid, linoleic acid, is the physiological precursor of the "l" and "2" 
series of eicosanoids. The pathway by which linoleic acid is converted 
to arachidonic acid (eicosatetraenoic acid) is illustrated in Figure 1. 
Linoleic acid is desaturated and elongated to form dihomo-gamma-
linolenic acid. The latter fatty acid is desaturated to form 
arachidonic acid. In general, arachidonic acid yields compounds with 
subscript "2" as in PGEg. Prostaglandins of the "l" series as in PGE^ 
are synthesized from dihomo-gamma-linolenic acid. 
Once absorbed, arachidonic acid is transported in the blood in 
several ways: bound to albumin, chylomicrons, and lipoproteins. 
Arachidonic acid is incorporated into the subcellular structures of 
tissues. In general, membrane phospholipids are the richest source of 
arachidonic acid. Arachidonic acid is enzymatically released by 
phospholipase A activity from the beta-position of the phospholipids in 
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the membrane upon mechanical, hormonal, and other stimulation. About 
20% of this arachidonic acid is available for eicosanoid metabolism via 
two pathways with the remainder being reacylated to phospholipids (3, 
5). 
One pathway of eicosanoid biosynthesis through lipoxygenase 
activity results in the formation of leukotrienes. These compounds are 
believed to have immunologic properties but the full importance of these 
substances is still not known (1, 15). A second pathway by 
cyclooxygenase activity leads to the formation of PG, PGI^, and TXAg as 
illustrated in Figure 1. These labile compounds are involved in the 
functions of the cardiovascular system (1) and platelets (2) and of 
lipid metabolism (14). 
Two steps are required for the formation of PG, PGIg, and TXAg 
following the release of arachidonic acid from tissue stores (Figure 1). 
The first step results in the formation of the cyclic endoperoxides, PGG 
and PGH. These cyclic endoperoxides are rapidly formed from arachidonic 
acid by cyclooxygenase in the presence of molecular oxygen. In the 
second step, these unstable and biologically active endoperoxides are 
converted to one or more compounds of the eicosanoid family by tissue-
specific synthetases or isomerases. 
Tissue-specific synthetases are involved in the formation of TXA^ 
and PGIg (Figure 1). Thromboxane synthetase, localized mainly in the 
platelets, catalyses the conversion of the endoperoxide to TXAg. This 
extremely labile eicosanoid has a half-life of about 30 seconds and is 
converted nonenzymatically to an inactive metabolite, thromboxane B2 
I 
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(TXBg). Localized in the vascular endothelium, prostacyclin synthetase 
activity results in the formation of PGI^ which has a biological half-
life of about 2 minutes. The most important physiological metabolite of 
PGIg is the biologically inactive 6-keto-PGF^a (Met-I^) (3). 
Tissue-specific isomerases are responsible for the formation of PG 
(Figure 1). Endoperoxide-E-isomerase activity on the arachidonic acid-
derived endoperoxides results in the formation of PGEg. PGEg is 
efficiently inactivated (90% in one pass) in the lungs. In contrast to 
PGEg, PGE^ is synthesized from dihomo-gamma-linolenic acid. It requires 
also the cyclooxygenase and isomerase activities. Similar to PGEg, 
circulating concentrations of PGE^ are low due to efficient inactivated 
by in the lung (3). 
In virtually every mammalian tissue, arachidonic acid is 
metabolized as illustrated in Figure 1. As implied earlier, one 
particular eicosanoid is made in greatest abundance by a specific cell 
type. For example, endothelial cells can produce PGEg and PGIg but PGIg 
production accounts for at least 90% of the total production. On the 
other hand, TXA^ is the most potent and quantitatively important 
metabolite formed in platelets (2). 
Although the eicosanoid family members are derived from the same 
precursor, they exhibit diverse and in many cases, opposing 
physiological effects (Table 1) (1, 3, 4). For example, circulating 
endogenous TXA^ constricts arteries and promotes platelet aggregation. 
In contrast, PGI^ relaxes vascular smooth muscle and inhibits platelet 
aggregation. PGEg relaxes vascular smooth muscle (similar to PGI^) and 
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promotes platelet aggregation (analogous to TXA^). PGE^ is similar to 
PGIg in its anti-aggregatory nature. 
It is generally considered that eicosanoids should be classified as 
intracellular messengers rather than as hormones (1, 3, 15). If a 
hormone is defined as a substance that is produced and stored in a gland 
for subsequent release into the circulation to act upon a distant target 
site, eicosanoids certainly do not qualify. There is no overwhelming 
evidence to indicate that they are stored as such, or that they respond 
to a physiological signal to act at a distant target site. They appear 
to behave analogously to cyclic adenosine monophosphate (cAMP). In this 
respect, they are synthesized rapidly within a given tissue and serve to 
modulate physiological processes locally. 
Many compounds can interfere with eicosanoid synthesis (2, 13). 
The effect of aspirin (acetylsalicylic acid) is probably the most widely 
known. Aspirin irreversibly and chemically inactivates cyclooxygenase. 
Biosynthetic activity is restored only when new enzyme protein is 
synthesized by the tissue. Hence, a dose of aspirin would have a longer 
inhibitory effect on platelet synthesis of escosanoids than on the 
endothelial production. Platelets do not possess the ability to 
synthesize protein, and eicosanoid activity returns only after new 
platelets have been formed. 
Plasma and Serum Eicosanoid Levels 
Conflicting results have been obtained in all facets of eicosanoid 
research. A major factor promoting this confusion stems in part from 
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TABLE 1. Effect of eicosanoids on vascular smooth muscle and platelet 
aggregation 
Elcosanoid Vascular Smooth Muscle Platelet Aggregation 
Prostaglandin E^ (PGE^) 
Prostacyclin (PGI^) 
Prostaglandin E^ (PGE^) 
Thromboxane (TXA^) 
unknown 
dilates 
dilates 
constricts 
inhibits 
inhibits 
promotes 
promotes 
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the investigative models. Eicosanoid research has been conducted on a 
full gamut of research models ranging from cell biology to human 
investigations usually in conjunction with a disease state. In vitro 
studies have used different experimental approaches during the 
investigations. For example, PGI^ synthesis is evaluated by using 
aortic strips or rings in various media. In vivo studies have been 
conducted by observing a physiological response during the infusion of 
PG or during the inhibition of eicosanoids by aspirin. The diversity in 
experimental approaches used makes it difficult to extrapolate the 
results from these investigations and apply them to a normal population 
group. 
There is growing interest in the significance of eicosanoid 
concentrations in body fluids during various clinical conditions in 
humans. This interest has been generated by the recognition that 
endogenous eicosanoids modulate the functional activities in many 
tissues. Most frequently, eicosanoid concentrations in serum, and to a 
lesser extent in plasma are being determined. But reports of eicosanoid 
values from blood vary widely (16), and comparison among the various 
studies becomes impossible. Thus, normal ranges of eicosanoid 
concentrations in serum and plasma are ill-defined. 
Many factors affect eicosanoid concentrations in blood and 
contribute to the disparity in reported values. Methodology is critical 
in eicosanoid research. The collection and processing of samples for 
eicosanoid analysis are not standardized. Variables such as temperature 
and duration of incubation, and centrifugation temperature influence 
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eicosanoid concentrations (16). In addition, the use of a cuff during 
the blood collection period may elevate eicosanoid concentrations (11). 
Second, samples must be processed immediately after blood is drawn (16). 
Samples from clinical studies may not be processed immediately due to 
inadequate facilities and insufficient personnel. Third, eicosanoid 
concentrations have been analyzed by gas chromatography, mass 
spectrometry, or radioimmunoassay (16, 17). The results from these 
techniques may not correlate well in samples from the same subject at a 
given time. Finally, the time blood is drawn in relation to the last 
meal affects eicosanoid concentrations in blood (11). Other factors 
such as exercise level (18), dietary intake (1, 5), and disease (1, 5) 
influence blood eicosanoid concentrations. 
Plasma eicosanoid concentrations theoretically reflect eicosanoid 
metabolism in the blood vessels. McGiff (3) indicates that plasma Met-
Ig concentrations reflect PGI^ synthesis by the vascular endothelium. 
Since PGE^ and PGE^ are efficiently inactivated by pulmonary 
circulation, concentrations of these eicosanoids may represent regional 
vascular synthesis in the area of the blood withdrawal. Storms (19) 
found significant correlations (r=0.6) among plasma PGE^, plasma PGEg, 
and PGIg in four insulin-dependent diabetics. These observations may 
suggest a similar origin, the vascular endothelium, for these 
eicosanoids. Presumably, plasma TXB^ concentrations indicate the amount 
of platelets synthesis during aggregation (4). 
Serum eicosanoid measurements are analogous to performing an 
aggregating platelet incubation (4). This ex vivo measurement provides 
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a physiologic biopsy technique for evaluating the rate and total 
eicosanoid synthesis during clotting (16, 20, 21). As mentioned 
earlier, TXA^ is quantitatively the most important serum eicosanoid. 
PGEg does not initiate platelet aggregation, but it is released during 
the aggregation process. 
Correlations between plasma and serum eicosanoids have not been 
examined adequately. The Department of Food and Nutrition at Iowa State 
University is one of the few institutions that is currently 
investigating this relationship. Some studies have been conducted at by 
the Department of Food Science and Nutrition in Colorado State 
University in Fort Collins, Colorado (16, 21). The significance of 
endogenous eicosanoid concentrations in blood warrants verification. 
Factors that Influence Eicosanoid Production 
Cardiovascular disease, diabetes mellitus. and aging 
One area that has received considerable attention is the role of 
PGIg and TXA^ in cardiovascular disease and diabetes. Cardiovascular 
disease and diabetes are in themselves related. For example, 
cardiovascular disease is an important risk factor for diabetes. A 
16-year follow-up study of the Framingham population (22) indicated that 
the mortality rate in diabetic subjects with cardiovascular disease was 
about three times higher than the rate in the general population. 
Recent research findings suggest that these disease states are 
accompanied by an imbalance in PGIg and TXA^ production (5, 7). 
Endothelial cells line the inner wall of the blood vessel. The 
I 
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study of these cells is under intense investigation because they are the 
first tissues injured during the development of cardiovascular disease 
(1, 14). It has been demonstrated that PGI^ production by the 
endothelial cells is decreased during the initial developmental stages 
of atherosclerosis (23). When PGI^ production is insufficient, 
platelets attach to the cell which in turn favor TXAg production (2). 
It is apparent that an optimum balance between PGIg and TXAg must be 
maintained to prevent damage to the endothelium. 
It has been suggested that an imbalance in eicosanoids, mainly PGI^ 
and TXAg, promotes the development of the microvascular changes observed 
in diabetics (8). In a diabetic condition, PGI^ production by the 
endothelial cells is lower compared to the synthesis in cells from an 
age-matched control population (7, 24). In addition, platelets 
aggregate more readily and TXAg synthesis is greater in diabetics than 
in age-matched control subjects (6). 
Plasma levels of Met-I^ which reflect PGI^ synthesis have been 
studied in diabetics and age-matched control groups. In general, Met-I^ 
concentrations are lower in the diabetics than in the nondiabetic 
control populations (25, 26). Some studies, however, report no 
differences in the Met-I^ concentrations between these two groups (27, 
28). The lack of consistency may be due to selection of subjects and 
blood sampling protocol used. 
The reasons offered for the PGIg/TXAg imbalance in cardiovascular 
disease and diabetes remain speculative. Several investigators have 
suggested that high circulating glucose concentrations lead to the 
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eicosanoid imbalance (6, 9, 29, 30). Many studies, however, give 
conflicting results on the relationship between glucose and eicosanoid 
concentrations (21, 31, 32). Recently, Lasche and Larson (33) reported 
that hyperinsulinemia, a risk factor for atherosclerosis development 
(34, 35), decreases PGI^ production by the vascular endothelium in the 
rat. In contrast, treatment of the aorta with insulin significantly 
increased PGIg production in diabetic and nondiabetic rats (7, 24). 
Other factors such as hypercholesterolemia (36, 37) and lipoprotein 
composition (5, 38, 39) may influence the balance between PGI^ and TXA^. 
Some research data suggest that the PGIg/TXAg imbalance may be part 
of the normal process of aging. Ylikorkala et al. (40) reported the 
effect of age on circulating PG concentrations in a normal human 
population. In general, Met-I^ concentrations were similar for males 
and females of the same age. Plasma Met-Ig concentrations were higher 
in the adolescent (10-20 years of age) than in healthy adults (30-50 
years of age). Chang and Tai (41) observed that PGIg production by rat 
aortas decreased with age. Although TXAg production in platelets did 
not change with age in the latter study, the reduced PGIg production 
would decrease the PGI^/TXA^ ratio. 
Dietary lipid intake 
The consumption of polyunsaturated fatty acids affects platelet 
aggregation. Hornstra et al. (42) found decreased platelet aggregation 
following ingestion of a diet consisting of 35% of the calories as fat 
with 12% linoleic acid compared to 4% as linoleic acid. Fleischman et 
al. (43) and O'Brien et al. (44) have reported similar results of the 
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beneficial effect of increased dietary linoleate upon platelet function 
in humans. 
The average consumption of linoleate in the United States is about 
2 to 5% of the total calories (45). It has been recommended that 
intakes be increased two to three times this range (46). Results from 
investigations of the effect of dietary linoleate on eicosanoid 
production, however, are conflicting (11, 47, 48, 49) and difficult to 
interpret (Table 2). Differences in experimental design used in these 
studies may account for some of the diverse results. Thus, the effect 
of dietary linoleate treatment on eicosanoid production is not 
predictable. Data by Dupont et al. (49) indicate an increased rate of 
eicosanoid produçtiqn with dietary linoleate above 20%; this suggests 
that excessive dietary linoleate may be detrimental. 
Nutritional state and eicosanoid synthesis 
Recently, it has been suggested that the nutritional state may 
affect eicosanoid synthesis. In this context, nutritional state of the 
experimental animal refers to the collection of blood samples for 
eicosanoid analysis in relation to the last meal: either under fasting 
(fasted) or postprandial (fed) conditions. Only a few studies have 
addressed specifically the effects of the nutritional state on 
eicosanoid production. 
Sullivan and Mathias (11) conducted one of the few thorough 
investigations that examines the effect of nutritional state on 
escosanoid production. They found that the synthesis of serum TXBg and 
PGEg differed significantly between fasted and fed blood samples. Serum 
TABLE 2. Effect of dietary linoleate treatment on eicosanoid production in the rat. 
Sex & Blood Level & type of 
Reference Duration Collection Dietary Fat& Effect 
Sullivan & Female Fasted & Fed No fat (0.0% linoleate) Serum PGE^,PGEg, & TXBg 
Mathias (11) 13 weeks BT (0.4% linoleate) depressed at 0% linoleate; 
BT:CO (14% linoleate) Syntheses greatest at 
CO (22% linoleate) 0.4% linoleate. 
SF (29% linoleate) 
Hwang et al. Male Fasted & Fed 40% total energy Serum PGE^ higher at 
(47) 2 months 1) BT (3.2% linoleate) 63% linoleate. 
2) HVF (29% linoleate) 
3) CO (63% linoleate) 
Fine et al. Male Fasted 20 or 40% of total Serum PGE2 not affected; 
(48) 8 & 11 weeks energy serum PGE^ higher with 20% 
P/S ratios (SB0:BT): than 40% fat calories. 
1) 0.4 
2) 0.8 
3) 5.5 
Dupont et al. Female Fed 0-27% linoleate calories Serum PGE^ & PGE2 increased 
(49) 6 months 1) BT at 0-2% kcal, increased at 
2) SBO 2-7% kcal, increased at 
3) SFO 7-27% kcal. Serum TXB2 
decreased at 2-20% kcal. 
increased at 27% kcal. 
^Abbreviations for dietary fat are: BT=beef tallow; BT:CO=beff tallow, corn oil; CO-corn oil; 
SF=safflower oil; HVF=dhyrogenated vegetable fat; SBO=soybean oil; and SFO=sunflower oil. 
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TXBg and PGEg concentrations in fasted samples were 62 and 48% higher, 
respectively, than were eicosanoids values in fed samples. The authors 
explained these findings on the basis of an increased norepinephrine 
activity associated with fasting. In this respect, norepinephrine 
elevates plasma free fatty acid concentrations which in turn induce 
platelet aggregation. In theory, this physiological response would 
stimulate platelet eicosanoid synthesis. Furthermore, they suggest that 
increased eicosanoid production during fasting is due to complex 
interactions among several factors: norepinephrine, platelet lipid 
turnover, and plasma free fatty acid composition. In addition to the 
well-known phospholipid precursor pool, they suggest that plasma free 
fatty acids may be also an important eicosanoid precursor pool. 
Sullivan and Mathias (11) reported another interesting finding in 
the same study. They examined concurrently the effects of dietary 
linoleate treatment on eicosanoid production in fasting and fed serum 
samples (Table 2). The effect of dietary linoleate was observed only in 
the fed samples. They reported that serum TXB^ and PGEg synthesis were 
depressed on a fat-free diet in the fed samples. Synthesis of these 
eicosanoids was highest during a 0.4% linoleate calories treatment (beef 
tallow). Moreover, serum TXB^ was depressed as the concentration of 
dietary linoleate increased from 14 to 29% linoleate calories. None of 
these changes were observed in the fasted serum samples. 
Only two human studies have examined the production of eicosanoids 
during different nutritional states. Storms (19) examined this 
relationship in four insulin-dependent diabetic patients. She found 
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that plasma PGE^ and PGEg concentrations were higher in the 12-hour 
fasting samples than the 2-hour or 4-hour postprandial samples. The 
nutritional state of her subjects, however, did not affect serum 
eicosanoid production. On the other hand, Greaves et al. (18) found 
PGE^ concentrations in whole blood were higher in the 1-hour 
postprandial samples than in the 12-hour fasted samples in human 
subjects. 
In humans, some evidence indicate that a postprandial state may 
stimulate eicosanoid synthesis, particularly serum TXAg and PGE^. The 
majority of the available data is based on studies that examine platelet 
activation, platelet adhesiveness, and platelet survival. In general, 
human platelets are activated by lipids, mainly saturated fats (50); 
this stimulation leads to increased platelet adhesiveness, increased 
platelet clumping, and decreased platelet survival. In theory, these 
phenomena would imply enhanced platelet eicosanoid synthesis. Results 
from human studies support these concepts. Lowe et al. (51) studied the 
effect of a saturated fat meal on the induction of circulating platelet-
aggregates in healthy volunteers. They found increased platelet 
aggregates and reduced platelet-counts 90 minutes after the meal. 
O'Brien et al. (44) also observed an increase in platelet adhesiveness 
and a decrease in platelet count following a polyunsaturated meal. 
Moolten et al. (52) found increased platelet adhesiveness in human 
subjects fed either low fat or high fat diets. The rise in 
adhesiveness, however, was significantly greater for the group receiving 
the high fat diet than for the low fat group. These findings suggest 
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that activation of platelets is associated with the fed condition. In 
turn, synthesis of serum eicosanoids, predominantly TXAg, would be 
stimulated. Platelet production of PGE^, and to a lesser degree PGE^, 
would also occur. 
Prostaglandins and Obesity 
It is well-documented that PG play an important physiological role 
in the regulation of lipid mobilization from adipose tissue (53, 54). 
Steinberg et al. (55) and Bergstrom and Carlson (56) were the first to 
report that PGE^ reduced basal and hormone-stimulated lipolysis in 
adipose tissue in vitro. It is generally accepted that eicosanoids, 
mainly PGE^ and PGEg, are involved in the maintenance of adipose tissue 
homeostasis by a negative feedback inhibition mechanism. In the normal 
adipose cell, cAMP formation (inducing lipolysis) and PG synthesis are 
in a finely balanced state. It has been hypothesized from in vitro 
studies that in obesity, PG synthesis is excessive causing a negative 
inhibition of the cAMP system (reducing lipolysis) at one or more steps. 
Hence, the mobilization of the triglyceride from adipose tissue is 
"tuned-off" and little, if any release of free fatty acids and glycerol 
is observed (10). 
The PG hypothesis of obesity is attractive but lacks supporting 
evidence. This view might imply that the inhibition of PG synthesis by 
aspirin and other non-steroidal anti-inflammatory drugs would be useful 
in the treatment of obesity. Breddin et al. (57) reported that 
significant weight loss did not occur in humans receiving doses of 
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aspirin at least five times higher than that required for complete 
inhibition of platelet PG. A daily dose of 1800 mg of aspirin for three 
days will completely inhibit eicosanoid production. 
Insulin and Glucose Levels in Relation to Body Weight Status 
A positive relationship exists between obesity and either fasting 
or glucose-stimulated insulin levels (58). In this respect, increasing 
relative body weights are associated with increments in basal insulin 
secretion in normal subjects. A study result by Kaplan and Leveille 
(59) strengthens this concept. Fasting and postprandial blood samples 
of obese females had significantly more insulin and glucose than samples 
of normal weight females. 
Recent reports showed that insulin and glucose levels are closely 
associated with the pattern of body fat distribution (60). Individuals 
with an upper-body-obesity (fat is distributed mostly above the waist) 
are more likely to develop diabetes than those with a lower-body-obesity 
(fat is predominantly on the hips and thighs). This theory is based on 
the insulin and glucose concentrations of women observed by Kissebah and 
associates (61, 62). They found that elevated insulin and glucose 
levels are more commonly associated with an upper-body-obesity compared 
to a lower-body-obesity. 
Weight Reduction and Maintenance of Weight Loss 
Although eicosanoid research has captured the attention of the 
scientific community in recent years, the preoccupation with body weight 
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continues to elicit universal interest and personal concern. Centuries 
ago, an overweight state was considered a status symbol and an object of 
artistic representation. But times have changed especially with the 
advent of Twiggy; a social stigma has become attached to obesity. Ayers 
(63) has presented the changing views toward overweight and obesity from 
the Greco-Roman times to the twentieth century. These are the esthetic 
views on body shape and form; health aspects are often overlooked. 
The Health and Nutritional Examination Survey (HANES) data (64) 
indicate that a large percentage of Americans exceed the recommended 
weights. Approximately, one-fifth (1.7 million) of females, 20-24 years 
of age, are 10% or more above the suggested weights for their heights. 
For females in the same age group, about one-tenth are 20% or more above 
the recommended weights. A greater percent of women than men in the 
same age groups have body weight above the suggested ranges. The 
percent deviations from the recommended weights for either sex increase 
with age. 
Weight reduction programs continue to proliferate into the public 
sector; they are lucrative business enterprises. When a new program is 
introduced, clientele invest hundreds and thousands of dollars in hopes 
that finally a "miracle" program has been discovered. Some of these 
"miracle" diets, such as the liquid-protein-diet, have proven lethal to 
some poorly-counseled patrons (65). Moreover, the dietary 
recommendations of these faddish programs do not produce favorable 
lean/fat (body compartments) ratio (66). The most undesirable outcome 
is that weight losses achieved are seldom maintained permanently 
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(67-69). 
The basic goals of a sensible weight reduction program are (1) to 
decrease caloric intake and (2) to increase caloric expenditure (67). 
Both of these objectives should be met in a moderate fashion and 
adequate nutrient intakes must be assured. A caloric intake below 1200 
kcal/day is not recommended; below this level, the Recommended Dietary 
Allowances (45) for essential nutrients are difficult to meet. 
Additionally, a daily physical exercise pattern needs to be adopted, 
although it need not be a strenuous regimen. 
The cyclic loss and regain of body weight has been popularly termed 
the 'yo-yo syndrome' (70). Bray (67) has evaluated the body weight 
patterns of obese individuals from long-term studies. He found that 10 
to 20% of the "dieters" will maintain their weight loss or continue to 
lose weight, but few will actually reach their recommended weights. 
Unfortunately, the remaining dieters will return to their pre-reduction 
weights, and some will exceed their initial levels. Usually, 
individuals are motivated to lose weight during the initial dieting 
period but many fail to make a lifetime commitment to modify their 
lifestyle. A strong individual commitment is imperative if body weight 
is to be properly controlled over a lifetime. One question raised is: 
How do you guide individuals to make such a commitment? 
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METHODS AND MATERIALS 
Body Weight Management Program (BWMP) 
The BWMP was designed to assist overweight college females lose 
body weight sensibly and maintain weight loss. The philosophy of the 
BWMP was to modify the eating habits and lifestyle of the participants 
while they maintained a familiar eating and living environment. This 
program was directed by the present investigator and offered to the 
female occupants in an ISU residence complex, Maple-Willow-Larch (MWL). 
The dietary guidance aspect was integrated into the program with the 
cooperation of the MWL Food Service Facility. Appendix A gives the 
following: a detailed description of the program, the computerization 
of the food service menu items, and a sample of the daily menu provided 
to the participants. Changes in body weights and a discussion of the 
cyclic weight loss patterns of these females are provided also in 
Appendix A. 
The Iowa State University Committee on the Use of Human Subjects in 
Research reviewed this project and concluded that the rights and welfare 
of the human subjects were adequately protected, that risks were 
outweighed by the potential benefits and expected value of the knowledge 
sought, that confidentiality of data was assured, and that informed 
consent was obtained by appropriate procedures. Supporting data for 
this approval are presented in Appendix B. 
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Description of Parcicipants 
The BWMP for the 1982-1983 school year began in September based on 
the encouraging results from a pilot study in May, 1982 (Appendix A). 
Of the 78 applicants, 29 females were selected to participate in the 
dietary counseling and blood sampling collection phases of the study. 
Five females (Subjects B, D, BB, T, and U) dropped out of the program 
within a couple of months. An additional four females (Subjects G, Al, 
A2, and Bl) enrolled in the program in November, 1982. The BWMP ended 
in April, 1983, after the final blood collection period. 
A general description of the 33 participants in the BWMP is given 
in Table 3. All were Caucasian females with relative body weights 
ranging from 106 to 152%. The body mass index [Wt (kg)/Ht (m)1.5] 
ranged from 29 to 40. The subjects were in good physical health as 
certified by a physician at the ISU Student Health Services prior to 
enrollment in the program. Most of the participants were in good 
academic standing, maintaining at least a 2.5 grade point average out of 
a possible 4.0. All of the subjects were non-smokers. No one was 
taking any type of medication throughout the study period. Only about 
one-half of the participants had regular menstrual cycles during the 
7-month period. 
Other characteristics of the 33 subjects are shown also in Table 3. 
The majority of the subjects (88%) indicated in a personal interview 
that they had lower-body-obesity compared to upper-body-obesity. Forty-
four percent reported being overweight before menarche. The remainder 
of the subjects (56%) had become heavier following the onset of their 
TABLE 3. Description of the females in the Body Weight Management Program experimental study, 
1982-1983 
Sub- Age Height IBW^ RBW^ RBW^ BMI*^ Obesity^ Onset^ RMR® 
ect (year) cm (in) [kg (in)] (%) (%) (kcal/ 
24 hr) 
A1 19 176.8 (69.6) 68.2 (150.0) 106 96 29 upper post 1207 
E 21 174.0 (68.5) 67.0 (142.4) 107 97 29 lower post 1631 
C 18 164.6 (64.8) 62.2 (136.8) 111 99 29 lower post 1485 
L 19 160.3 (63.1) 60.3 (132.7) 112 99 30 lower post 1584 
I 20 167.6 (65.0) 63.6 (139.9) 112 100 29 lower post 1415 
K 20 171.3 (67.4) 67.8 (149.2) 112 100 30 lower post 1267 
A2 19 174.7 (68.7) 69.9 (153.8) 112 101 30 lower post 1111 
B 19 162.8 (64.1) 62.6 (137.7) 113 101 30 lower post 1234 
B1 19 167.6 (66.0) 66.0 (145.2) 113 101 30 upper post 1111 
D 18 165.2 (65.0) 64.7 (142.3) 114 101 30 lower post 1468 
H 19 168.2 (66.2) 67.3 (148.1) 115 103 -31 lower post 1630 
J 21 156.7 (61.7) 61.6 (135.5) 119 106 31 lower post 1285 
M 21 167.0 (65.7) 68.4 (150.5) 119 106 32 lower post 1267 
P 21 173.7 (68.4) 74.3 (163.5) 119 108 33 lower post 1500 
S 19 177.7 (70.0) 81.3 (178.9) 125 113 34 lower pre 1853 
FF 22 167.8 (66.1) 73.8 (162.4) 126 113 34 lower post 1482 
Q 20 161.5 (63.6) 68.7 (151.1) 126 113 34 lower pre 1354 
u 18 169.5 (66.7) 74.9 (164.8) 127 114 34 lower pre 1593 
0 20 170.7 (67.2) 77.3 (170.1) 129 115 35 lower pre 1494 
T 19 154.5 (60.8) 65.5 (144.1) 130 115 34 lower pre 1633 
R 18 161.2 (63.5) 70.5 (155.1) 130 115 35 lower post 1350 
X 20 169.5 (66.7) 76.8 (169.0) 130 116 35 lower pre 1578 
N 19 168.2 (66.2) 77.3 (170.1) 132 118 35 lower post 1402 
Y 19 169.8 (66.9) 79.0 (173.8) 132 118 36 lower pre 1676 
W 20 164.9 (64.9) 76.0 (167.2) 134 119 36 lower post 1723 
Z 21 167.6 (66.0) 79.6 (175.1) 136 122 37 upper pre 1606 
V , 19 167.9 (66.1) 81.0 (178.2) 138 124 37 lower post 1639 
AA 20 164.9 (64.9) 80.8 (177.8) 142 127 38 lower pre 1594 
G 20 164.6 (64.8) 81.7 (179.7) 145 129 39 lower post unk 
BB 19 173.4 (68.3) 91.5 (201.3) 147 132 40 lower pre 1845 
EE 19 167.6 (66.0) 87.6 (192.7) 150 134 40 lower post 1368 
CC 21 153.9 (60.6) 76.5 (168.3) 152 134 40 upper pre 1348 
DD 19 156.7 (61.7) 78.6 (172.9) 152 134 40 lower pre 1843 
^Initial body weights (IBW) were recorded on the first blood collection period (Sept. '82) 
at the Student Health Services. 
Relative body weights (%) were calculated by desirable^body''JSght ^  1°°. 
Desirable body weights were based on the Hathaway and Foard (71) measurements. 
^Relative body weights (%) were calculated as described in footnote "b" above. Desirable 
body weights were based on the HANES (64) measurements which were estimated from regression 
equation of weight on height for women aged 20-29 years. 
^Body Mass Index, W/H (in Kg/m^'^). 
^Obesity refers to pattern of body fat. Lower indicates a lower-body-obesity (fat is 
predominately on the hips and thighs) and upper refers to upper-body-obesity (fat is 
distributed mostly above the waist). This information was obtained from a personal interview 
with each participant of the BWMP. 
^Onset of obesity refers to premenarche (overwieght during childhood) and postmenarche (excess 
weight following the onset of the menstrual cycle). 
®RMR denotes resting metabolic rate. Standard procedures (72) were used to obtain these 2-hour 
postprandial measurements. 
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menstrual cycle (around 10 to 12 years of age). Again, this information 
was obtained from each participant in a personal interview by this 
investigator. Their resting metabolic rates (Spirometer, Warren E. 
Collins, Inc., Boston, MA) ranged from 1111 to 1853 kcal/24 hours. 
Dietary intakes were not analyzed in this study. 
Most of the participants had a family history for obesity, 
diabetes, and hypertension (Table 4). The majority of the participants 
(n=21) reported that at least one immediate family member was overweight 
by at least 25 pounds. Diabetes (adult-onset) and hypertension were 
present also among the family members of a number of the participants. 
This information was also self-reported. 
Blood Sample Collection 
The original plan of the BWMP was to obtain a 12-hour fasting 
(fasted) blood sample and a 2-hour postprandial (fed) blood sample from 
the participants at various stages during their weight reduction. These 
samples were to be collected (1) immediately before the restricted 
caloric intake period, (2) when a relative weight of 125% (if relative 
weight was 150%) was achieved, (3) when a relative weight of 100+10% was 
reached, and (4) several months after a relative weight of 100+10% had 
been achieved and stabilized (see page 94, Appendix B). 
The original blood collection schedule was not followed due to the 
erratic body weight changes of the participants. Instead, blood samples 
were obtained at the beginning (September, n=28) and end (April, n=24) 
of the BWMP. Blood samples were collected also in December (n=10) from 
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TABLE 4. Presence of obesity, adult-onset diabetes, and high blood 
pressure in family members of the females in the Body Weight 
Management Program* 
Subject Obesity Diabetes Hypertension 
A1 
E M/F/S 
C GF 
L F 
I F 
K F/GF F 
A2 F 
B M/B B 
B1 F 
D 
H F/S M 
J GM GM M 
M GF/F 
P GF GM 
S GF GM 
FF M/F/S/B M 
Q 
u F U 
0 GF 
T S 
R M/F 
X 
N M/F 
Y M/F/B 
W 
Z M/F F 
V F 
AA M/F/B F 
G 
BB M/F/S/GF GF 
EE F U 
CC GF 
DD M A 
^A personal interview was conducted with each participant in the 
program concerning the presence of these disease statesj among 
family members. Thus, the presence of these states is jsubject to 
individual interpretation. Obesity is defined as 25 po'unds or more 
above suggested weights for their heights. Diabetes artd a hyper­
tensive state prevailed when dietary and/or drugs were required. 
Thejfollowing abbreviations indicate the presence of these disease 
states among family members: F=father, GF=grandfather, !M=mother, 
S=sister, GM=grandmother, A=aunt, U=uncle, and B=brother. 
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four newly enrolled participants and six females who had lost about one-
half of the weight they desired to lose. 
The participants were instructed not to take any medication 
including aspirin 10 days prior to the blood collection day. The 
inhibition of eicosanoid synthesis by aspirin has been reviewed earlier. 
It is believed that the participants complied with this request. Many 
blood samples could not be collected at the specified stages due to the 
frequent usage of aspirin for menstrual cramps and headaches. 
Blood was withdrawn by venipuncture with the use of a cuff by a 
medical technologist at the ISU Student Health Service. The 12-hour 
fasting samples (fasted) were obtained before breakfast and the 2-hour 
postprandial samples (fed) were collected after the noon meal on the 
same day. 
Collection methods for plasma and serum eicosanoids have been 
described previously (16) and are probably the most crucial phase of 
eicosanoid assays. The following modified procedure was followed for 
the collection and the immediate processing of samples for plasma 
eicosanoids, serum eicosanoids, plasma insulin, and plasma glucose, 
respectively. First, blood for plasma eicosanoid analyses was drawn 
into a 10 ml vacutainer tube containing 1.0 ml of a disodium 
ethylenediamine tetraacetate (EDTA)-aspirin solution. This tube was 
inverted and placed on ice for 10 minutes. Second, blood for serum 
eicosanoids was drawn into vacutainer tube (5 ml) without anticoagulant-
eicosanoid interfering substances and was allowed to clot for exactly 10 
minutes in a water bath at 37°C. The 10-minute timing began as blood 
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was drawn into the tube. Serum eicosanoid production was stopped by 
adding 0.5 ml of 4.2 mM aspirin in a 0.1 M potassium phosphate buffer 
(pH 7.4). Third; blood for the plasma insulin and glucose assays was 
obtained in a 7 ml heparinized vacutainer tube and remained at room 
temperature for exactly 10 minutes. All of these three tubes were 
centrifuged (unrefrigerated) at 2000xg for 10 minutes. 
Further processing of the samples was performed at the Student 
Health Services. Following the removal of platelets from the blood by 
centrifugation, 200 pi aliquots were pipetted for plasma PGE^, PGEg, and 
Net-Ig analyses. A 400 jil aliquot was measured for the plasma TXBg 
assay. Aliquots for serum eicosanoid assays were not made immediately. 
The serum was removed by aspiration, transferred to one tube and stored 
at -20°C. Prior to the laboratory analyses, the serum was thawed at 
room temperature. Aliquots of 300 ]il and 50 yl were taken for the serum 
PGE^ and PGEg analyses, respectively. A 200 yl aliquot from a 1/10 
dilution in phosphate buffered saline (PBS) - 0.1% gelatin was made for 
the serum TXB^ assay. Plasma for the insulin and glucose analyses was 
removed and stored in two separate tubes. Aliquots of 100 yl and 10 yl 
were taken prior to the insulin and glucose analyses, respectively. All 
tubes were stored at -20°C until laboratory analysis. Assays for plasma 
eicosanoid, insulin, and glucose levels were performed when plasma was 
thawed for the first time (16). Duplicate aliquots were measured for 
all assays. 
The incubation of blood for serum eicosanoid analysis is termed an 
ex vivo incubation (20). Whole blood was allowed to clot for exactly 10 
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minutes at 37°C. Addition of aspirin was then used to stop eicosanoid 
synthesis. The measurement of serum eicosanoids is the amount of 
eicosanoid synthesized in a 10-minute period in the absence of an 
exogenous substrate. It is assumed that this measurement is indicative 
of the ability of tissues to synthesize eicosanoids in vivo. Generally, 
it is believed that plasma eicosanoid measurements are indicative of 
endogenous vascular release of PGIg, PGE^, and PGE^. As mentioned 
previously, aspirin is present in the vacutainer tube as the blood is 
drawn into the tube. This prevents further eicosanoid synthesis. 
All of the samples for eicosanoid, insulin, and glucose analyses 
from one female were evaluated in the same assay run. Moreover, the 
fasted and fed samples from one subject were analyzed alternately in the 
assay run. When results of the duplicate samples did not agree within 
10%, both the fasted and corresponding fed sample were reassayed. 
Analytical Methods 
Eicosanoid assay 
Fasted and postprandial serum samples were assayed for PGE^, PGE^, 
and TXBg. Likewise, plasma samples were analyzed for PGE^, PGEg, TXBg, 
and also Met-Ig. The radioimmunoassay procedure by McCosh et al. (17) 
was used for the eicosanoid analyses. 
This radioimmunoassay method is based upon the double-antibody 
procedure. Briefly, it involves the overnight pre-precipitation of 
anti-rabbit gamma globulin with the specific antibody. This suspended 
pre-precipitated antisera solution is mixed with duplicate unknown 
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samples and tritiated standards, and a 24-hour precipitation period is 
then required. Finally, the tubes are centrifuged and prepared for 
counting by liquid scintillation. 
Results were analyzed by use of a computer program obtained from 
Lousiana State University (73). This program plotted the percent bound 
of labelled antigen as a function of the quantity of unlabelled antigen 
added versus a log transformation of the standard concentrations. 
Insulin analysis 
Insulin concentrations were determined in the fasted and fed plasma 
samples. An insulin kit (Code IM.78, Amersham, Arlington Heights, IL 
60005) was used for this quantitative measurement. A 96-hour incubation 
period was used instead of the usual 3-hour incubation. This 
modification was necessary to obtain more sensitive measurements of the 
insulin concentrations below 10 microunits/ml. 
In general, the modified procedure involved a 24-hour incubation of 
anti-insulin serum (guinea pig) with samples and standard insulin. 
These samples were incubated for an additional 72 hours with ^^®I-
insulin prepared from purified bovine insulin. The insoluble antigen-
antibody complex was then separated from the soluble free insulin by 
centrifugation. By counting the radioactivity in the precipitate from 
both standards and sample unknowns, a standard curve was constructed and 
unknown insulin levels were interpolated. 
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Glucose analysis 
Glucose concentrations were measured in the fasted and postprandial 
plasma samples. A method based on the use of glucose oxidase (GOD) as 
reported by Raabo and Terkildsen (74) was used. 
Briefly, the procedure is based on the following enzymatic 
reactions. 
Glucose + 2 H-O + 0. > Gluconic Acid + 2 H„0 
Glucose Oxidase 
HgOg + O-Dianisidine > .Oxidized 0-Dianisldine 
(Colorless) Peroxidase (Brown) 
Following a 30-minute incubation at 37°C, the samples were promptly read 
on a spectrometer (Gilford 240) at 450 nm. 
Glucose concentrations of the samples were calculated by dividing 
the absorbance of the sample unknown by the absorbance of a glucose 
standard. This value was multiplied by 100. Absorbance of the standard 
solution was verified by a standard curve (slope = 1). The accuracy and 
precision of the the glucose oxidase method was verified by a Moni-trol 
I Chemistry (DADE Division, Miami, FL) control solution. 
Statistical Analysis 
Data were analyzed using the paired t-test. Students' t-test, 
analysis of variance and Duncan's Multiple Range Test with the 
Statistical Analysis System (SAS Institute, Gary, N.C.). Correlation 
coefficients were also calculated. The statistical probability of 0.05 
was considered significant. 
35 
RESULTS 
The effects of the nutritional state (fasted and fed) on 
eicosanoid, insulin and glucose concentrations are presented in Table 5. 
Paired t-test showed that the 2-hour postprandial serum samples 
contained significantly (P50.01) more TXB^ than did the 12-hour fasted 
samples. Plasma insulin concentrations were significantly (P<0.0001) 
higher in the fed state compared to the fasted condition. Plasma 
glucose and all of the other eicosanoid concentrations examined did not 
differ significantly between the two collection periods. 
Several significant relationships based on correlation coefficients 
were found for the parameters measured in this study (Table 6). During 
a fasted state, more significant correlations among the various 
eicosanoids were obtained than in the fed state. Serum PGE^ synthesis 
correlated with most of the eicosanoids measured in the fasted 
condition. Significant correlations of eicosanoids with both glucose 
and body weight were found during the fed state. 
Fasted and fed eicosanoid concentrations were examined separately 
(paired t-test) during the three blood collection periods (September, 
December, and April). Except for serum TXB^, no significant differences 
were found between the fasted and fed samples. The absolute 
concentrations of these parameters may have been higher or lower during 
a specific month but differences due to the nutritional states were not 
significant. On the other hand, serum TXB^ concentrations in the fed 
samples were significantly (PSO.OOOl) greater compared to fasted samples 
in Septemper (Table 7). In December, the serum TXB^ concentration was 
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TABLE 5. Eicosanoid, insulin, and glucose concentrations^ in fasted and 
fed blood samplesb in overweight females 
Parameter Fasted Fed Level of 
Significance 
Serum PGE^ 
Serum PGEg 
Plasma PGE^ 
Plasma PGEg 
Serum TXBg 
Plasma TXBg 
Plasma Met-I^ 
Plasma Insulin 
Plasma Glucose 
0.93 ± 0.12 
0.56 ± 0.09 
1.18 ± 0.16 
2.08 ± 0.31 
15.80 ± 2.77 
4.56 + 0.28 
0.19 ± 0.03 
23.5 ± 1.7 
69.4 ± 1.5 
0.96 ± 0.12 
0.58 ± 0.09 
1.02 ± 0.14 
1.96 ± 0.30 
22.18 ± 1.78 
4.46 ± 0.28 
0.19 ± 0.05 
49.7 ± 4.4 
70.3 ± 1.7 
P < 0.01 
P < 0.0001 
^Eicosanoid, insulin, and glucose concentrations are expressed as 
ng/ml, yl/ml, and mg%, respectively. Data were analyzed by the 
paired t-test. 
'^Fasted (12-hour) and fed (2-hour; postprandial) blood samples were 
obtained from a total of 33 females during September and/or December 
and/or April. Means ± SEM are based on a total of 61 blood samples 
for each fasted and fed state. 
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greater in the fed samples than in the fasted samples but the difference 
was not significant (P30.06). In April, serum TXB^ concentrations were 
similar for the two collection periods. 
In general, eicosanoid concentrations were not significantly 
related to the three indices of body fatness: body weight, relative 
body weight, and body mass index based on Duncan's Multiple Range Test. 
However, there was a significant positive correlation between Met-Ig 
concentration and body weight during the fed state (Table 6). 
Eicosanoid concentrations were not affected by a loss or gain in body 
weight or body-type-obesity (students' t-test). The onset of obesity 
(premenarche or postmenarche) had no effect on eicosanoid 
concentrations, except for serum PGE^. Serum PGE^ concentrations were 
significantly greater in the females with childhood obesity 
(premenarche, 1.29 ± 0.24 ng/ml) compared to a postmenarche obese 
individual (0.73 ± 0.10 ng/ml). 
Some relationships were found between glucose and eicosanoid 
concentrations in this research (Table 6). The fasting glucose level 
was negatively correlated to serum PGE^ concentration (r=-0.32, PSO.Ol). 
During the fed state, positive correlations were found for glucose 
concentration with serum PGEg concentration and with plasma TXBg 
(r=+0.32, PSO.Ol). 
Glucose and insulin concentrations were not related to loss or gain 
in body weight, body-type-obesity, or onset of obesity of the 
participants based on the students' t-test. During a fed state, a 
positive relationship (r=+0.56, P<0.0001) was found between glucose and 
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TABLE 6. Relationships between eicosanoids, insulin, and glucose 
concentrations in fasted and fed blood samples^ in overweight 
females 
Parameters Fasted Fed 
r Level of 
Significance 
r Level of 
• Significance 
Serum PGE^ A Serum PGE^ +0.41 P<0.001 +0. 41 P<0.001 
Serum PGE. * Plasma PGE^ +0.51 P<0.0001 +0. 53 P<0.0001 
Serum PGE. * Serum TXBg -0.32 P<0.01 
Serum PGE * Plasma PGEg -0.31 P<0.02 
Serum PGE^ * Plasma TXBg +0.30 P<0.02 
Serum PGEg * Plasma TXBg +0.50 P<0.0001 +0. 50 P<0.0001 
Serum TXB^ * Plasma PGE^ -0.39 P<0.005 
Serum TXBg * Plasma PGEg +0.36 P<0.005 
Plasma Met-
^2* 
Plasma PGE^ +0.54 P<0.0001 +0. 34 P<0.02 
Plasma PGE^ * Plasma PGEg -0.38 P<0.005 -0. 36 P<0.01 
Serum PGE^ * Plasma Glucose -0.32 P<0.01 
Serum PGEg * Plasma Glucose +0. 32 P<0.01 
Plasma TXBg * Plasma Glucose +0. 32 P<0.01 
Plasma Glucose^Plasma Insulin +0. 56 p<o.6ooi 
Plasma GlucoseaRBW^ +0. 34 P<0.01 
Plasma Met-Ig* Body Weight +0. 33 P<0.01 
lasted (12-hour and fed (2-hour) postprandial blood samples were 
obtained from a total of 33 females during September and/or 
December and/or April. Partial correlations were based on a total 
of 61 blood samples for each fasted and fed state. 
^Relative body weights were based on the Hathaway and Foard (71) 
measurements. 
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insulin concentrations (Table 6). Additionally, glucose concentrations 
and relative body weights were positively correlated during a fed state 
(Table 6). 
In the present study, a seasonal effect on eicosanoid production 
may be present. Analysis of variance of data from 19 females (only 19 
of the 33 participants had blood samples taken in both September and 
April) indicated that serum TXB^, serum PGE^, serum PGE^, plasma PGE^, 
and plasma PGEg concentrations differed significantly in the September 
blood samples compared to the April samples. For example, September 
samples had significantly (P<0.0001) less serum TXB^ (Figure 2) and 
plasma PGE^ (Figure 3) than the April samples. In fact, plasma PGE^ 
concentrations in April were about 4 times higher than in September. 
Differences in serum TXB^ were even more pronounced. 
On the other hand, plasma PGE^, serum PGE^, and serum PGE^ 
concentrations responded in an opposite fashion to serum TXB^ and plasma 
PGEg. September blood samples showed significantly (PS0.0005) more 
plasma PGE^ (Figure 3), serum PGE^ (Figure 4), and serum PGEg (Figure 4) 
than the April samples. Although not significant, fasted and fed 
concentrations of Met-I^ were higher in September than in April (Figure 
2). Plasma TXB^ concentrations in September and April were similar. 
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TABLE 7. Serum thromboxane concentration^ in fasted and fed 
samples^ from overweight females in three different months 
Level of 
Month Fasted Fed Significance 
September, 1982 4.99 ± 2.11 14.16 ± 3.25 P < 0.0001 
(n = 28) 
December, 1982 10.99 ± 3.44 22.35 ± 7.71 NS 
(n = 10) 
April, 1983 31.76 ± 5.42 31.87 ± 4.64 NS 
(n = 24) 
^Synthesis of TXB^ (Mean ± SEM; mg/ml) is during 10 minutes of ex 
vivo clotting in blood samples. Data were analyzed by the pair 
t-test. 
^Fasted (12-hour) and postprandial (2-hour) blood samples were 
collected. 
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FIGURE 2. Effect of season on plasma prostacyclin (Met-Ig) 
and serum thromboxane (TXB-) in fasted (12-hour) 
and fed (2-hour) blood samples in overweight 
females 
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FIGURE 3. Effect of season on plasma PGE% and plasma PGEg levels in 
fasted (12-hour) and fed (2-hour) blood samples in 
overweight females 
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FIGURE 4. Effect of season on serum PGE. and serum PGE_ 
levels in fasted (12-hour) and fed (2-hour) blood 
samples in overweight females 
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DISCUSSION 
Information is available on eicosanoid concentrations in body 
fluids, such as serum and plasma in normal, healthy individuals but the 
results reported are contradictory. In the present study, a number of 
eicosanoids in both plasma and serum samples in humans, were evaluated. 
Early investigations, usually on an in vitro basis, focused on 
prostaglandins of the E series. Since the discovery of PGIg and TXA^ in 
the late seventies, research has been conducted mainly on these two 
labile eicosanoids. Most of the studies, mainly in vitro, investigated 
PGIg production in the endothelium and/or TXA^ synthesis by the 
platelets (1, 3). Human studies are beginning to explore eicosanoid 
concentrations in serum and plasma especially in relation to diabetes 
and cardiovascular disease (16, 21, 25, 27, 31). 
A paucity of information exists on several other aspects of the 
present investigation. First, only a few investigators have examined 
specifically the effect of the nutritional state (fasting vs fed) on 
eicosanoid concentration (11, 18, 19, 47). The results from these 
studies are contradictory. Some research results indicate that feeding, 
especially unsaturated fatty acids, stimulates platelet activity in 
humans (50, 51, 52). In contrast, plasma free fatty acid levels are 
elevated in a fasting state. Thus, greater amounts of free fatty acids 
would be available for eicosanoid synthesis. Second, the relationship 
between body weight and eicosanoid concentration in blood has not been 
studied in a human population. Based on in vitro studies, it has been 
suggested that PG production is excessive in the obese state (10). 
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Finally, the seasonal variation of eicosanoid concentrations has never 
been documented. 
The results from the present study indicate that a fed state 
stimulates TXB^ synthesis in humans. Platelet eicosanoid synthesis was 
responsive to the fed condition, as indicated by the significantly 
higher serum TXBg concentration in the fed samples than in the fasted 
samples (Table 5). The increased serum TXB^ concentration suggests that 
platelet activation occurs upon feeding in humans. This activation 
would be associated also with an increased platelet adhesiveness and an 
increased platelet clumping. These in vitro observations have been 
verified by other investigators (44, 50, 51, 52). 
Although platelets synthesize predominately TXA^, PGE^ and to a 
lesser extent PGE^ also are released during the aggregation process (3). 
Mean concentrations of PGEg and PGE^, however, were not increased 
significantly during the fed state compared to the fasted period. In 
humans, serum PGE^ and serum PGE^ synthesis do not appear to be 
sensitive to a nutritional state due to the selective production of 
TXBg. 
In this study, the observation that feeding stimulates serum TXBg 
synthesis in humans contradicts the results obtained by Sullivan and 
Mathias (11) in the animal model. In rats, they observed that compared 
to the fed state, fasting increased serum TXB^ and PGE^ concentrations 
by 62 and 48%, respectively. Moreover, the significant effects of 
various dietary linoleate treatments on eicosanoid concentrations were 
detected only in the fed samples. Due to the opposing results of these 
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two investigations, one might speculate that the apparent discrepancy is 
species specific. Lipoprotein fractions differ between the rat and 
human model (75, 77) and the contribution of these fractions to 
eicosanoid concentrations has not been elucidated. 
The relationships between plasma and serum eicosanoids were 
interesting, but in some cases, were difficult to interpret due to the 
lack of previous documentation (Table 7). In this study, some 
correlation coefficients reflect opposing physiological effects of 
eicosanoids on platelet aggregation (Table 6). For example, a 
significant negative correlation (r=-0.38, fasted; r=-0.36, fed) between 
plasma PGE^ and plasma PGEg was found. A significant positive 
correlation was found between plasma PGE^ and Met-I^, both of which 
inhibit platelet aggregation (1, 2, 14). Significant positive 
relationships were found in serum and/or plasma samples between PGEg snd 
TXBg, both of which promote platelet aggregation (1, 2, 14). But the 
same trends failed with the following positive significant correlations: 
between serum PGE^ (inhibits) and serum PGEg (promotes), and between 
serum PGE^ (inhibits) and plasma TXB^ (promotes). These direct 
correlations between eicosanoids with opposing physiogical effects on 
platelet aggregation may be anomalous. 
The energy balance status of the participants differed between the 
three blood collection periods (September, December, and April). The 
original plan of the Body Weight Management Program was to obtain a 
blood sample before weight loss in September (baseline samples at 
initial body weights). The September blood collections, however, were 
47 
obtained from the participants (n=29) during the first two weeks of a 
negative energy balance. This occurred because once the participants 
had been notified of their acceptance into the BWMP, they began 
immediately to restrict their caloric intake. The December blood 
collection (n=10) is based on six females who had lost one-half of the 
weight (ranging from -3.4 to -9.1 kg) they desired to lose and four 
females who had been in the program for about one month (enrolled in 
November). By this time, weight loss had slowed down possibly due to 
physiological adaptation to the energy deficit. In addition, the energy 
deficit may have been smaller in December compared to September. In 
April, energy balance had returned to pre-reduction levels as indicated 
by the body weight gain in the majority of the females (n=24) (Appendix 
A). 
The effect of energy balance on eicosanoid production has not been 
documented. Although feeding may stimulate platelet activation 
(inducing TXB^ production), energy balance may explain in part the 
different effects of the nutritional state on TXBg synthesis. To 
illustrate the effect of energy balance on serum TXB^, fed/fasted ratios 
of serum TXB^ levels were calculated (Table 7). The fed/fasted ratio 
approached a value of 3 during the initial phase of weight loss 
(September). As weight loss slowed down due to adaptation (December), 
the ratio decreased to a value of 2. A fed/fasted ratio of 1 was found 
during weight maintenance or weight gain of the females (April). 
Differences due to energy balance were not found for the other 
eicosanoids examined in the present study. 
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It is known that subjects in negative energy balance, lipolysis is 
increased in order to use fatty acids as a source of energy (68). Under 
these circumstances, linoleic acid is used as an energy source rather 
than being elongated to synthesize arachidonic acid. This might suggest 
that in September, a relative arachidonic acid deficiency was present, 
explaining the lowest TXB^ concentration by platelets in the fasting 
blood samples (Table 8). After feeding (postprandial blood samples), 
more arachidonic acid would be available to be utilized by platelets, 
which may account for the increase in TXBg concentration in relation to 
fasting. After a metabolic adaptation had occurred in December, the 
need of linoleic acid as a source of energy would be decreased, making 
it more available for arachidonic acid synthesis and TXBg production. 
In April, the energy balance had returned to pre-reduction levels, and 
more arachidonic acid would be available. 
The effect of energy balance was not observed in Met-I2 and PGEl 
concentrations. These two eicosanoids produce vasodilation and both are 
synthesized by adipocytes (10, 78). It has been suggested that an 
increase in synthesis of these two eicosanoids occurs during lipolysis 
in order to increase the blood flow through the adipose tissue and the 
fatty acid transport to the liver (79). This might explain the decrease 
in these eicosanoid concentrations in April. 
An imbalance in eicosanoid production has been associated with 
clinical manifestations of diabetes and cardiovascular disease. In 
vitro study results suggest that circulating glucose levels may promote 
a decreased PGI^ production from endothelial tissue and/or an increased 
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TXBg synthesis by platelets (6, 9, 29, 30). Other results indicate that 
eicosanoid concentrations are not influenced by circulating glucose 
levels (21, 31, 32). 
The observed relationships between glucose and eicosanoids in the 
present study reflect this complex relationship. Fasting glucose levels 
were inversely related to serum PGE^ concentration (Table 6). A similar 
association was found by Storms (19) in diabetic patients. In contrast, 
postprandial glucose levels were positively correlated to serum PGEg and 
plasma TXBg levels. Although the mean glucose concentrations did not 
differ significantly between the fasted and 2-hour postprandial samples 
(Table 5), glucose levels after feeding might have a latent effect on 
serum PGEg and plasma TXB^ synthesis. The increased concentrations of 
glucose (e.g., a 1-hour postprandial sample) may trigger a subsequent 
increase in the PGEg and TXBg concentrations. This particular response 
of eicosanoid production to increased glucose concentrations may be 
associated with the development of certain pathological conditions. 
Unfortunately, the onset of these conditions may not become apparent 
biochemically for some time after the initial aberration. 
In addition to the 2-hour postprandial blood samples, a 1-hour fed 
sample was obtained from 10 of the 29 subjects in September. Regardless 
of the 1-hour or 2-hour sample collection, the relationships between 
eicosanoid, insulin, and glucose remained the same as those presented in 
Table 6. As expected, the 1-hour fed samples had significantly 
(P30.0001) higher glucose concentrations than the fasted samples. 
A 2-hour fed sample rather than a 1-hour sample was chosen to 
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compare the present findings to those reported by Storms (19). Using 
the same antiserum to measure eicosanoid concentrations as in this 
study, she examined eicosanoid and free fatty acid levels in 2-hour and 
4-hour postprandial samples from four insulin-dependent diabetic 
subjects during various dietary treatments. Plasma PGE^ and plasma PGEg 
concentrations were greater during the fasting state compared to the fed 
condition in her subjects. In the present study, mean concentrations of 
plasma PGE^ and PGEg did not differ significantly between the two 
collection periods. Recently, fasted and 2-hour postprandial blood 
samples have been collected from ten normal weight females during a 
metabolic balance study. The results from this particular study are 
forthcoming and will provide further insight into the effects of the 
nutritional state on eicosanoid production. 
Relative body weights were significantly and positively correlated 
to postprandial glucose concentrations (Table 6); this result is 
consistent with the findings by Bagdade et al. (58). As expected, 
postprandial glucose concentrations were positively correlated to 
postprandial insulin concentrations. Mean concentrations of fasted and 
fed glucose and insulin for these overweight females were within a 
normal range (77). Kissebah and associates (61) found elevated insulin 
and glucose concentrations in upper-body-obese females. Relationships 
between body-type-obesity to insulin and glucose concentrations could 
not be verified in this research due to the limited number of upper-
body-obese females (Subjects Al, Bl, A, and C), as well as the 
subjective criterion used for judging body-type-obesity. 
I 
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It has been suggested that prostaglandin synthesis, mainly PGE^ and 
PGEg, is excessive in obesity and may inhibit the release of free fatty 
acids and glycerol from adipose tissue (10). In the present in vivo 
study, concentrations of PGE^, PGEg, and also TXBg were not related to 
the indices of body fatness. It has been reported that adipose tissue 
produces significant amounts of PGI^ (79). Consequently, a positive 
association between plasma Met-I^ and body weight (Table 6) may be 
explained by an increased amount of adipose tissue and an increased 
production of Met-I^ by this tissue. Moreover, the total amount of 
blood vessels is greater in obese people than in normal weight 
individuals; thus, the total amount of endothelium available for Met-I^ 
production is also greater in obesity. 
A seasonal effect on eicosanoid concentrations has not been 
reported in the literature although Dupont has observed this phenomenon 
(personal communication, Department of Food and Nutrition, ISU). In 
general, parallel trends were evident for the eicosanoids having a 
similar effect on platelet aggregation regardless of plasma or serum 
origin. Plasma PGE^ (Figure 3) and serum PGE^ (Figure 4) concentrations 
were significantly less in April than in September. Although not 
significant, both fasted and fed Met-Ig concentrations (Figure 2) tend 
to be less in April than in September. 
The lower concentrations of the anti-aggregatory eicosanoids (PGE^ 
and Met-I,) from September to April is accompanied by significantly 
higher concentrations of serum TXB^ (Figure 2) and plasma PGEg (Figure 
3). Again, it is evident that a balance is maintained for most of the 
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eicosanoids having opposing effects on platelet aggregation. The 
decline in serum PGEg concentration (Figure 4) in April compared to 
September may be anomalous. At present, no explanations can be offered 
for the seasonal trends observed in this study. Eicosanoid degradation 
during storage can be excluded since some of the levels increased during 
the sample storage period. Morris et al. (16) have conducted one of the 
more thorough investigations on the variables that affect eicosanoid 
concentrations. They do not indicate that the length of sample storage 
has any effect on eicosanoid production. Precautions suggested by these 
researchers include the immediate processing of samples and the 
evaluation of eicosanoid concentrations after the initial thawing of 
samples. These factors were controlled in the present study. 
The relative concentrations of eicosanoids in body fluids in humans 
are unknown. Examination of the mean values and standard deviations 
from many studies indicates wide variability (27, 28, 40). Eicosanoid 
concentrations varied widely also in this study (Table 5). In addition, 
concentrations of eicosanoids in serum may not represent the true blood 
levels. For example, the plasma PGEg concentration is higher than the 
serum PGEg concentration (Table 5). As suggested by Morris and 
associates (16), plasma eicosanoid concentrations may be higher than 
serum concentrations due to "artifactual increases in plasma 
concentrations." Moreover, calculations of plasma PGE^ concentrations 
were difficult due to this artifactual increase. In agreement with 
other studies (1-3), TXB^ in platelets was the most important 
quantitatively (Table 5). 
53 
Many factors affect eicosanoid concentration. Methods used in the 
collection and processing of samples influence assay results. 
Eicosanoid concentrations will vary depending upon techniques used such 
as radioimmunoassay, gas chromatography, or mass spectrometry (16, 17). 
The latter two methods are not suitable for large numbers of samples. 
Radioimmunoassay is a precise and rapid means for quantifying eicosanoid 
concentrations in blood. Other factors such as exercise levels in 
humans (18), dietary fat (50-52), and nutritional state (11, 18, 19) 
have been found to affect these concentrations also. 
As mentioned earlier, the time of the sample collection and 
eicosanoid assay were similiar for the study by Storms (19) and the 
present investigation. For example, (1) 12-hour fasting and 2-hour 
postprandial blood samples were collected, (2) serum and plasma 
eicosanoid concentrations were determined in the same laboratory 
facility using the same reagents and methodology, and (3) the first and 
second blood collection tubes were used for the plasma and serum 
eicosanoid assays, respectively. Eicosanoid results from the two 
studies, however, differed greatly (Table 8). It is known that 
diabetics have lower concentrations of Met-I^ than normal subjects (6, 
7, 8, 24). A comparison of the Met-Ig concentrations from the diabetic 
patients in the study by Storms and the present investigation certainly 
support this assumption (Table 8). However, the differences in the Met-
Ig concentrations, as well as the other eicosanoids, between these two 
studies cannot be attributed to background of the subjects. 
The blood drawing technique was different in the study by Storms 
54 
TAÎBLE8. Elcosanoid concentrations^ in fasted blood samples from the 
overweight females in the present research (Struempler) and 
from the study by Storms 
b c 
Struempler Storms Study 1 _ . 
(Study 1) (Study 2) Study 2 **tio 
Plasma TXBg 4560 151 30.2 
Plasma Met-Ig 190 2.5, 74.5 
Serum TXBg 15800 41600 0.38 
Serum PGE^ 930 215 4.33 
Plasma PGE^ 1180 475 2.48 
Serum PGEg 560 823 0.68 
Plasma PGEg 2080 544 3.82 
^Eicosanoid concentrations, pg/ml. 
^Overweight college females (n=33) were the participants in Study 
1 by Struempler (present investigation). 
"^The eicosanoid levels reported by Storms (19) are based on four 
insulin-dependent adults. 
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(19) than in the present investigation. The blood samples were drawn 
using an in-dwelling catheter that had been put in the forearm vein of 
the hospitalized diabetic patients examined by Storms. In contrast, the 
blood samples from the free-living women in the present study were 
obtained by venipuncture with the use of a cuff. 
It has been reported that ischemia produced by a cuff during blood 
collection increases eicosanoid concentrations (11, 80). During the 
first minute of ischemia occlusion, the eicosanoid concentrations are 
believed to be the highest (80). In addition, Morris et al. (16) have 
indicated that any problems encountered during blood collection, such as 
slow withdrawal of blood and/or manipulation of the needle, will 
increase eicosanoid concentrations. These observations would explain 
the elevated concentrations for the plasma eicosanoids as indicated by 
the higher ratios in the present study compared to those reported by 
Storms (19) (Table 8). 
In summary, the present investigation contributes valuable 
information related to eicosanoid concentrations. The results suggest 
that several factors influence eicosanoid concentrations in blood. 
Nutritional state and/or energy status of the individual affect these 
concentrations. But additional observations on normal human subjects 
are necessary to confirm these observations. These apparent effects 
emphasize the need for the adoption of a standardized procedure for the 
collection and processing of blood samples for eicosanoid assays. 
Further research on eicosanoid concentrations in serum and plasma is 
required. Moreover, blood collection for serial eicosanoid 
56 
concentrations in humans should be obtained within the shortest time 
span possible. This would minimize any possible seasonal effect on 
eicosanoid concentrations. 
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CONCLUSIONS AND RECOMMENDATIONS 
Eicosanoid concentrations in serum and plasma are of recent 
interest especially in relation to pathological conditions, such as 
diabetes mellitus and cardiovascular disease. In the present study, 
eicosanoid concentrations in overweight college women were examined. 
Eicosanoid measurements included plasma PGE^, PGEg' TXB^, and Met-I^; 
serum levels of PGE^, PGE^, and TXBg also were evaluated. Blood samples 
were obtained from 33 participants in a Body Weight Management Program 
which emphasized weight reduction by moderate and sensible changes in 
dietary and lifestyle habits. 
Many factors affect eicosanoid concentrations in serum and plasma. 
In the present study, at least three factors were found to influence 
eicosanoid concentration. They include: 
(1) Effect of Nutritional State: Nutritional state of these 
females refers to the collection of blood samples for eicosanoid 
analysis in relation to the last meal: a 12-hour fasting (fasted) and a 
2-hour postprandial (fed) blood sample. Serum TXB^ was the only 
eicosanoid examined that was affected by the nutritional state. The 
2-hour postprandial serum sample produced significantly more TXB^ that 
did the 12-hour fasted sample. The increased serum TXB^ concentration 
suggests that platelet activation occurs upon feeding in humans. This 
observation contradicts the effect of the nutritional state on 
eicosanoid production in the rat. It has been reported that serum TXB^ 
and PGEg concentrations are greater in fasted samples compared to fed 
samples in the rat. One might speculate that the apparent discrepancy 
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is species specific. Lipoprotein fractions differ between the rat and 
human model and the contribution of these fractions to eicosanoid 
concentrations has not been elucidated. 
(2) Effect of Energy Balance: Energy balance was based on 
body weight changes of the females and for different periods, three 
patterns were observed: (1) an initial weight reduction period when 
weight loss was most rapid (September), (2) an intermediate weight 
period when weight loss slowed down possibly due to adaptation 
(December), and (3) the final phase when body weights for the majority 
of the females had returned to or exceeded pre-reduction levels (April). 
In addition to the nutritional state effect, energy balance may 
influence serum TXBg levels (based on fed/fasted ratios). For serum 
TXBg concentrations, the fed/fasted ratios were 2.8, 2, and 1 for the 
September, December, and April samples, respectively. In this respect, 
the difference between the fed and fasted serum TXB^ levels was more 
pronounced during a negative energy balance period. As energy balance 
approached or exceeded pre-reduction levels (positive), serum TXBg 
concentrations did not differ significantly between fed and fasted 
samples. This observation was not found for the other eicosanoids 
measured in this study. The effect of energy balance on eicosanoid 
concentrations has not been documented in the literature. 
(3) Seasonal Effect: Eicosanoid concentrations from the 
September and April blood samples were significantly different in the 
present study. In general, parallel trends were evident for the 
eicosanoids having a similar effect on platelet aggregation. The 
59 
concentrations of the anti-aggrcgatory eicosanoids (PGE^ and Met-I^) 
were higher in September than in April. In contrast, the concentrations 
of the pro-aggregatory eicosanoids, PGEg (in plasma) and TXB^ (in 
serum), were significantly lower in September than in April. These 
results may suggest a seasonal effect upon eicosanoid concentrations, 
although an interaction between energy balance and season should not be 
ruled out. A seasonal effect on eicosanoid concentrations has not been 
reported in the literature and requires verification. To control for. 
any possible seasonal effect on eicosanoids, it might be recommended 
that blood collection for serial eicosanoid assays in humans should be 
obtained within the shortest time span possible. 
These results suggest that several factors may influence eicosanoid 
concentrations in blood. Nutritional state or possibly the energy 
balance status of the individual affects these concentrations. But 
additional observations on normal human subjects are necessary to 
confirm these observations. These apparent effects on eicosanoid 
concentrations emphasize the need for the adoption of a standardized 
procedure for the collection and processing of blood samples for 
eicosanoid assays. More data are needed on eicosanoid concentrations in 
serum and plasma. 
Several significant correlations were found for the parameters 
evaluated in this investigation. Numerous relationships were found 
among the eicosanoid family members but their physiological significance 
is not known. In addition, body weights and blood glucose 
concentrations of the females were related to some of the eicosanoid 
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levels. Two correlations found were; 
(1) Met-Ig Concentrations and Body Weights; A positive 
relationship was found between Met-I^ concentrations and body weights of 
the overweight and obese women. The greater amounts of adipose tissue 
and blood vessels (both of which product Met-Ig) in a obese person 
compared to a normal weight individual justify this relationship. Body 
weight was not significantly related to the other eicosanoids. 
(2) Eicosanoid and Glucose Concentrations; Fasting glucose 
concentrations were inversely related to serum PGE^ concentrations 
(inhibits platelet aggregation). Postprandial glucose concentrations 
were positively associated to serum PGEg and plasma TXB^ concentrations 
(promotes platelet aggregation). In this respect, elevated circulating 
glucose concentrations may be associated with increased eicosanoids 
concentration, and these in turn, with the development of certain 
disease states such as diabetes and cardiovascular disease. Studies 
have addressed the effect of blood glucose on eicosanoid production but 
the results are complex. Further in vivo and in vitro investigations 
are needed. 
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APPENDIX A: BODY WEIGHT MANAGEMENT PROGRAM (BWMP) 
The Body Weight Management Program (BWMP) was designed to assist 
overweight college females lose body weight sensibly and maintain weight 
loss. The philosophy of the BWMP was to modify the eating habits and 
lifestyle of the participants while they maintained a familiar eating 
and living environment. This program was directed by the present 
investigator and offered to the female occupants in an Iowa State 
University (ISU) residence complex, Maple-Willow-Larch (MWL). The 
dietary guidance aspect was integrated into the program with the 
cooperation of the MWL Food Service Facility. The initiation and 
evaluation of the BWMP were two of the objectives for the dissertation 
research of this investigator. A third objective was to obtain blood 
samples from the females for the analyses of prostaglandins 
(eicosanoids), insulin, and glucose. 
The Iowa State University Committee on the Use of Human Subjects in 
Research reviewed this project and concluded that the rights and welfare 
of the human subjects were adequately protected, that risks were 
outweighed by the potential benefits and expected value of the knowledge 
sought, that confidentiality of data was assured, and that informed 
consent was obtained by appropriate procedures. Supporting data for 
this approval are presented in Appendix B. 
The integration of the BWMP into a food service facility was unique 
and had several advantages. The main advantage was that the 
participants of the program used meal tickets which they had purchased. 
Essentially, the program provided guidance to a group of free-living 
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students at no cost to the participants. Many weight reduction programs 
charge fees for the counseling and monitoring of body weight changes. 
Also, the University encourages the development of health programs that 
would benefit both students and employees. 
A food service facility offered also a method of controlling food 
quality and food quantity. These aspects were evaluated during the 
developmental phase of the BWMP by this investigator. This phase 
involved the development of a computerized data bank for all of the food 
items available from the MWL Food Service Facility. 
Development of Computerized Data Bank 
Computerization of the food choices offered by the food service 
involved the following protocol. First, the food purchasing facility at 
ISU identified the food purchased for the food service system at ISU. 
Once acquainted with this information, it was relatively simple, but 
tedious, to determine the quality (caloric density) of the food items. 
For example, the caloric density of meats is based on the lean-to-fat 
ratio and must be qualified for a weight reduction program. Second, 
main entree food items are prepared from standardized recipes in the 
food service. These recipes were obtained and coded accordingly based 
on data provided in Handbook 456 (1). Third, portion control is well-
regulated in a food service facility. For example, a 10x12 inch pan of 
meatloaf is divided into a specific number of individual servings. 
Based on these data, a computer printout provided the energy and 
nutrient contents for individual servings of the food choices available 
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in the food service. These data were then entered into the WYLBUR 
computer system. 
Daily menus were prepared from the WYLBUR data bank and provided to 
the participants of the BWMP. An example of a daily menu is presented 
in the following three pages. The menus listed all of the food choices 
available from the food service facility for a specific day. Daily food 
choices with the corresponding caloric density are listed on the menu. 
Daily intakes ranging from 1200 to 1700 kilocalories were recommended. 
Suggestions were provided on the menus to assist the participants in 
maintaining this caloric range. See samples on pages 72, 73, and 74. 
Food groups were assigned also to the food choices on the menu. 
Food groups were determined subjectively based on the amount of 
carbohydrate, fat, and protein as a percent of the total energy. This 
information was obtained from the computer printout. The subjects were 
encouraged to follow a basic four food group plan plus an empty-calorie 
allowance. The square boxes at the end of the menu indicate the 
recommended number of servings from each group. In addition, the 
participants were encouraged to anticipate and annotate the following 
day's intake before the actual consumption. For example, the dietary 
intake for Wednesday should be planned on Tuesday. Columns indicating 
the planned and actual dietary intakes are provided also on the menu. A 
more complete description of the menu system used in the BWMP is 
provided in Appendix C. 
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WEEK: Sample Menu SUBJECT LErrER 
Code 
No. 
Planned 
Intake 
Menu I t em Food Actual 
Group Intake 
B R E A K !• A S T 
2288 
2288 
1071 
27 
1433 
126 
126 
59R 
1317 
2049 
Chilled Fruit Juice 
1 serving, Tomato (30 kcal) 
1 serving, V-8 (30 kcal) 
1 serving, Grapefruit (60 kcal) 
1 serving, Apple (75 kcal) 
1 serving, Orange (80 kcal) 
Bacon 
2 si. bacon (100 kcal) 
1 si. bacon (50 kcal) 
Pancakes w/ Syrup 
1 ladle, 1 pancake (210 kcal) 
Margarine, 1 pat (35 kcal) 
1 level tbsp. Syrup (50 kcal) 
Fc 
Fc 
Fc 
Fc 
Fc 
00 
0 
0 & 
0 
S 
or 
461 
461 
1317 
1149 
Toast/English Muffin 
1 si (65 kcal) 
2 si (130 kcal) 
Margarine, 1 pat (35 kcal) 
Jolly/Jam, 1 tbsp. (50 kcal) 
Cereal 
1 box, Cold (100 kcal) 
4 oz., ] ladle, Hot (100 kcal) 
C 
CC 
0 
S 
C 
C 
L U N C H  
20R 
461 
1314 
653 
56R 
Potato Soup 
4 oz., 1 ladle (90 kcal) 
Chipped Beef and Cheese Sandwich 
2 si buttered' bread (130 kcal) 
1/4C & 1/4D 
CC & 00 
1 si cheese (80 kcal) 1/2M or 1/2D 
1 oz., 1 scoop C.B. Mix (45 kcal) 1/4M & 1/20 
or 
32 
93R 
Pork Chow Mein on Rice^ 
1/4 c., 1 scoop rice^(70 ^cal) 
1 ladle chow mein (235 kcal) 
1/2C 
M & 0 
Salad Bar 
WEEK: 
Code Planned 
No. Intake 
370 
126 
2394 
90R 
33R 
Menu Item 
73 SUBJECT LETTER 
Food 
Group 
Actual 
Intake 
D I N N E R  
Salisbury Steak - Bacon Wrapped (NO GRAVY) 
4 oz., 1 serving (310 kcal) M & 0 
1 si bacon (50 kcal) 0 
or 
Veal Parmegiana - Breaded Veal Cutlet 
w/ Sauce and Cheese 
2.8 oz., cooked veal (175 kcal) M & 0 
(REMOVE CHEESE, BREADING & CHEESE) 
Veal w/ sauce and cheese (310 kcal) M & 00 & S 
O'Brien Potatoes (OMIT) 
1 serving (300 kcal) 
Green Bean Casserole 
1/4 c., 1 scoop (75 kcal) 
Cooked Beets 
1/4 c., 1 scoop (15 kcal) 
1/2C & 0000 
1/2V & 1/20 
1/2V 
Salad Bar 
Milk, skim 
1322 4 oz., (1/2 c) (45 kcal) 1/2D 
. 8 oz., (1 c.)(90 kcal) D 
Other Additions to Menu/Snacks/Alcohol 
Serving Difficulties; 
Comments : 
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Procedure for Planning and Calculating the Dietary Intake 
Step 1: 
Step 2: 
Review menu. 
Decide on food choices and annotate food group and kcal in Plan» Int. column 
Step.3: Totals : M C D F V E kc 
Fc Vg 
Step 4: Subtract: 
Step 5: Determine additional food choices and annotate food group and kcal 
in Plan. Int. column. 
Step 6: Add steps 
3 & 5: 
Step 7: Following snack/meal, circle food group letters and mark kcal in 
Act. Int. col. 
Daily Totals 
Meat 
( 2 )  
Cereal 
(4) 
Dairy 
(2)  
Vege. 
(1) 
•  • • •  
Vege.-gr. 
(1) 
(3-4x/wk) 
Fruit 
(1) 
Fruit-C 
(1) 
Empty 
(max 4) 
Kcal 
1200-1700 
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Breakfast Weigh-in Meetings 
The body weights of the participants were monitored on a weekly 
basis at Andrews House, the metabolic unit at ISU. After the weights of 
the females had been recorded, a self-service continental breakfast was 
provided. In addition to the emphasis on weight reduction, the BWMP 
included an educational program, primarily stressing health and 
wellness. The breakfast weigh-in meetings provided the opportunity to 
discuss a variety of topics on a group basis (Table A-1). Individual 
counseling sessions were available to the females on a weekly basis. 
Pilot Study 
A pilot study was conducted to determine the effectiveness of the 
dietary phase of the BWMP. Ten, moderately overweight females 
volunteered to participate in the 4-week study (April-May, 1982). 
Changes in the body weights of the females are presented in Table A-2. 
Weight loss ranged from -0.6 to -5.8 kg with a mean weight loss of -3.4 
kg during the 4-week period. Five of the females participated in the 
long-term BWMP experimental study, 1982-1983. 
Long-Term Experimental Study, 1982-1983 
Description of participants 
The BWMP for the 1982-1983 school year began in September based on 
the encouraging results from a pilot study in May. Of the 78 
applicants, 29 females were selected to participate in the dietary 
counseling and blood sampling collection phases of the study. Five 
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TABLE 9. Discussion and workshop sessions presented during the Body 
Weight Management Program 
Anthropometric Measurements 
Body Composition During Body Weight Changes 
Body Frame Assessment 
Recommended Dietary Allowances 
Height and Weight Tables 
Basal Metabolic Rate 
Exercise 
Snacking 
Caloric Density 
Eating Behavior Modification 
Mental Modification 
Cooking/Shopping Tips 
Vitamin/Mineral Supplements 
Hypertension 
General Health and Wellness 
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females (Subjects B, D, BB, T, and U) dropped out of the program within 
a couple of months. An additional four females (Subjects G, Al, A2, and 
Bl) enrolled in the program in November, 1982. The BWMP ended in April, 
1983, after the final blood collection period. 
A general description of the 33 participants in the BWMP is given 
in Table A-3. All were Caucasian females with relative body weights 
ranging from 106 to 152%. The body mass index [Wt (kg)/Ht (m)1.5] 
ranged from 29 to 40. The subjects were in good physical health as 
certified by a physician at the ISU Student Health Services prior to 
enrollment in the program. Most of the participants were in good 
academic standing, maintaining at least a 2.5 grade point average out of 
a possible 4.0. All of the subjects were non-smokers. No one was 
taking any type of medication throughout the study period. Only about 
one-half of the participants had regular menstrual cycles during the 
7-month period. 
Other characteristics of the 33 subjects are shown also in Table 
A-3. The majority of the subjects (88%) indicated in a personal 
interview that they had lower-body-obesity compared to upper-body-
obesity. Forty-four percent reported being overweight before menarche. 
The remainder of the subjects (56%) had become heavier following the 
onset of their menstrual cycle (around 10 to 12 years of age). Again, 
this information was obtained from each participant in a personal 
interview by this investigator. Their resting metabolic rates 
(Spirometer, Warren E. Collins, Inc., Boston, MA) ranged from 1111 to 
1853 kcal/24 hours.. Dietary intakes were not analyzed in this study. 
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TABLE 10. Body weight changes for ten females in the Body Weight 
Management Program four-week pilot study (April - May, 1982) 
Subject Age RBW^ Body Weights 
(years) (%) (Kg) 
Initial Final Change 
(I) (II) (I-II) 
100 (DD)^ 19 162 83.8 78.0 - 5.8 
101 21 111 67.3 63.8 - 3.5 
103 (FF) 21 129 75.8 71.3 - 2.5 
104 (Y) 19 135 80.1 75.9 - 4.2 
105 19 112 63.3 61.8 - 1.5 
106 20 119 62.7 62.1 - 0.6 
107 20 114 67.9 64.1 - 3.8 
109 (E) 20 114 71.2 67.0 - 4.2 
110 (N) 19 132 77.2 74.8 - 2,4 
111 21 118 78.2 75.9 - 2.3 
X 20 125 72.8 69.5 
— 3,1 
SEM 0.32 5.06 2.31 2.02 0.47 
^Relative body weights (%) were calculated by 
detlr%ie^body%eight ^  Desirable body weights were based 
on the Hathaway and Foard (2) measurements. 
^Letter designations in parentheses indicate the respective 
participant who continued in the long-term experimental study 
(September, 1982 to May, 1983). 
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Many of the participants had a family history for obesity (n=21), 
diabetes (n=4), and hypertension (n=12) (Table A-4). The majority of 
the participants (n=21) reported that at least one immediate family 
member was overweight by at least 25 pounds. Diabetes (adult-onset) and 
hypertension were present also among the family members of a number of 
the participants. This information was also self-reported. 
Changes in body weight 
Changes in the body weights of the participants in the BWMP are 
presented in Table A-5. Initial body weights in September ranged from 
60.3 to 91.5 kg with a mean weight of 72.8 kg. Thirteen weeks later in 
December, six females had lost about one-half of the weight they had 
desired. These weight losses ranged from -3.4 to -9.1 kg. Upon 
completion of the BWMP in April, body weights ranged from 56.1 to 96.2 
kg with a mean weight of 71.9 kg. This resulted in only a mean weight 
loss of 0.9 kg for the entire study period. These weights were recorded 
on the blood collection days at the Student Health Services. 
The lowest body weights achieved by the participants during the 
BWMP are included also in Table A-5. These body weights were recorded 
at the weekly breakfast weigh-in meetings. It is evident that all of 
the participants except one female (subject E) lost weight at some point 
during the program. For the majority of the females, these losses were 
not maintained. 
TABLE 11.' Description of females in the Body Weight Management Program experimental study,. 
1982-1983. 
Sub­ Age Height IBW* RBW^ RBW*^ BMI*^ Obesity^ Onset^ RMR® 
ject (year) cm (in) [kg (in)] (%) (%) (kcal/ 
24 hr) 
A1 19 176.8 (69.6) 68.2 (150.0) 106 96 29 upper post 1207 
E 21 174.0 (68.5) 67.0 (142.4) 107 97 29 lower post 1631 
C 18 164.6 (64.8) 62.2 (136.8) 111 99 29 lower post 1485 
L 19 160.3 (63.1) 60.3 (132.7) 112 99 30 lower post 1584 
I 20 167.6 (65.0) 63.6 (139.9) 112 100 29 lower post 1415 
K 20 171.3 (67.4) 67.8 (149.2) 112 100 30 lower post 1267 
A2 19 174.7 (68.7) 69.9 (153.8) 112 101 30 lower post nil 
B 19 162.8 (64.1) 62.6 (137.7) 113 101 30 lower post 1234 
B1 19 167.6 (66.0) 66.0 (145.2) 113 101 30 upper post nil 
D 18 165.2 (65.0) 64.7 (142.3) 114 101 30 lower post 1468 
H 19 168.2 (66.2) 67.3 (148.1) 115 103 31 lower post 1630 
J 21 156.7 (61.7) 61.6 (135.5) 119 106 31 lower post 1285 
M 21 167.0 (65.7) 68.4 (150.5) 119 106 32 lower post 1267 
P 21 173.7 (68.4) 74.3 (163.5) 119 108 33 lower post 1500 
S 19 177.7 (70.0) 81.3 (178.9) 125 113 34 lower pre 1853 
FF 22 167.8 (66.1) 73.8 (162.4) 126 113 34 lower post 1482 
Q 20 161.5 (63.6) 68.7 (151.1) 126 113 34 lower pre 1354 
U 18 169.5 (66.7) 74.9 (164.8) 127 114 34 lower pre 1593 
0 20 170.7 (67.2) 77.3 (170.1) 129 115 35 lower pre 1494 
T 19 154.5 (60.8) 65.5 (144.1) 130 115 34 lower pre 1633 
R 18 161.2 (63.5) 70.5 (155.1) 130 115 35 lower post 1350 
X 20 169.5 (66.7) 76.8 (169.0) 130 116 35 lower pre 1578 
N 19 168.2 (66.2) 77.3 (170.1) 132 118 35 lower post 1402 
Y 19 169.8 (66.9) 79.0 (173.8) 132 118 36 lower pre 1676 
W 20 164.9 (64.9) 76.0 (167.2) 134 119 36 lower post 1723 
Z 21 167.6 (66.0) 79.6 (175.1) 136 122 37 upper pre 1606 
V 19 167.9 (66.1) 81.0 (178.2) 138 124 37 lower post 1639 
•AA 20 164.9 (64.9) 80.8 (177.8) 142 127 38 lower pre 1594 
G 20 164.6 (64.8) 81.7 (179.7) 145 129 39 lower post unk 
BB 19 173.4 (68.3) 91.5 (201.3) 147 132 40 lower pre 1845 
EE 19 167.6 (66.0) 87.6 (192.7) 150 134 40 lower post 1368 
CC 21 153.9 (60.6) 76.5 (168.3) 152 134 40 upper pre 1348 
DD 19 156.7 (61.7) 78.6 (172.9) 152 134 40 lower pre 1843 
^Initial body weights (IBW) were recorded on the first blood collection period (Sept. '82) 
at the Student Health Services. 
^Relative body weights (%) were calculated by ^gg^^able^body^wieght ^ 100. Desirable body 
weights were based on the Hathaway and Foard (2) measurements. 
^Relative body weights (%) were calcualted as described in footnote "b" above. Desirable body 
weights were based on the HANES (3) measurements which were estimated from regression 
equation of weight on height for women aged 20-29 years. 
^ody Mass Index, W/H (in Kg/m^*^). 
^Obesity refers to pattern of body fat. Lower indicates a lower-body-obesity (fat is pre­
dominantly on the hips and thighs) and upper refers to upper-body-obesity (fat is distributed 
mostly above the waist). This information was obtained from a personal interview with each 
participant of the BWMP. 
^Onset refers to premenarche (overweight during childhood) and post menarche (excess 
weight following the onset of the menstrual cycle). 
®RMR denotes resting metabolic rate. Standard procedures (4) were used to obtain these 
2-hour postprandial measurements. 
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Discussion 
The preoccupation with body weight continues to elicit universal 
interest and personal concern. Centuries ago, an overweight state was 
considered a status symbol and an object of artistic representation. 
But times have changed especially with the advent of Twiggy; a social 
stigma has become attached to obesity. Ayers (5) has presented the 
changing views toward overweight and obesity from the Greco-Roman times 
to the twentieth century. These are the esthetic views on body shape 
and form; health aspects are often overlooked. 
The Health and Nutritional Examination Survey (HANES) data (3) 
indicate that a large percentage of Americans exceed the recommended 
weights. Approximately, one-fifth (1.7 million) of females, 20-24 years 
of age, are 10% or more above the suggested weights for their heights. 
For females in the same age group, about one-tenth are 20% or more above 
the recommended weights. A greater percent of women than men in the 
same age groups have body weight above the suggested ranges. The 
percent deviations from the recommended weights for either sex increase 
with age. 
Weight reduction programs continue to proliferate into the public 
sector; they are lucrative business enterprises. When a new program is 
introduced, clientele invest hundreds and thousands of dollars in hopes 
that finally a "miracle" program has been discovered. Some of these 
"miracle" diets, such as the liquid-protein-diet, have provend lethal to 
some poorly-counseled patrons (6). Moreover, the dietary 
recommendations of these faddish programs do not produce favorable 
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TABLE 12. Presence of obesity, adult-onset diabetes, and high blood 
pressure in family members of the females in the Body Weight 
Management Program* 
Subject Obesity Diabetes Hypertension 
A1 
E M/F/S 
C GF 
1. F 
I F 
K F/GF F 
A2 F 
B M/B B 
B1 F 
D 
H F/S M 
J GM GM M 
M GF/F 
P GF GM 
S GF GM 
FF M/F/S/B M 
Q 
u F U 
0 GF 
T S 
R M/F 
X 
N M/F 
Y M/F/B 
W 
z M/F F 
V F 
AA M/F/B F 
G 
BB M/F/S/GF GF 
EE F U 
CC GF 
DD M A 
personal Interview was conducted with each participant in the 
program concerning the presence of these disease states among family 
members. Thus, the presence of these states is subject to individual 
interpretation. Obesity was defined as 25 pounds or more. Diabetes 
and a hypertensive state prevailed when dietary and/or drug treat­
ments were required. The following abbreviations Indicate the 
presence of these disease states among family members; F=father, 
GF=grandfather, M=mother, S=sister, GM=grandmother, A=aunt, U=uncle, 
and B=brother. 
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lean/fat (body compartments) ratio (7). The most undesirable outcome is 
that weight losses achieved are seldom maintained permanently (8-10). 
The basic goals of a sensible weight reduction program are (1) to 
decrease caloric intake, (2) to increase caloric expenditure, and (3) to 
establish new dietary and lifestyle habits that will maintain the body 
weight loss. The first two objective should be met in a moderate 
fashion and adequate nutrient intakes must be assured. A caloric intake 
below 1200 kcal/day is not recommended; below this level, the 
Recommended Dietary Allowances (11) for essential nutrients are 
difficult to meet. Additionally, a daily physical exercise pattern 
needs to be adopted, although it need not be a strenuous regimen. 
During the actual weight reduction period, the individual should be 
acquiring new dietary and lifestyle habits to ensure maintenance of body 
weight loss. Most dieters fail in this area (9, 10). Usually, 
individuals are motivated to lose weight during the initial dieting 
period but many fail to make a lifetime commitment to modify their 
lifestyle. A strong individual commitment is imperative if body weight 
is to be properly controlled over a lifetime. One question raised is: 
How do you guide individuals to make such a commitment? 
The weight loss patterns for the majority of the females in this 
study are disappointing. They are, however, realistic and similar to 
those observed in other weight reduction programs. Bray (8) has 
evaluated the body weight patterns of obese individuals from long-term 
studies. He found that 10 to 20% of the "dieters" will maintain their 
weight loss or continue to lose weight, but few will actually reach 
TABLE 13. Changes in body weight^ and lowest body weight achieved^ for the females in the Body 
Weight Management Program 
Subj ect Body Weight (Kg) 
Initial Intermediate Change Final Change Lowest Change 
(Sept. '82; I) (Dec. '82; II) (I-II) (Apr. '83; III) (I-III) (IV) (I-IV) 
A1 68.2 67.7 - 0.5 66.9 - 1.3 
E 67.0 74.8 + 7.8 67.5 + 0.5 
C 62.2 62.0 - 0.2 56.1 - 6.1 
L 60.3 55.8 - 4.5 56.1 - 4,2 55.8 - 4.5 
I 63.6 59.7 - 3.9 61.0 - 2.6 59.5 - 4.1 
K 67.8 64.0 - 3.4 68.8 + 1.0 63.8 - 4.0 
A2 69.9 67.8 — 2.1 65.5 - 4.4 
B 62.6 59.9 - 2.7 
B1 66.0 69.4 + 3.4 65.5 - 0.5 
D 64.7 54.6 -10.6 
H 67.3 66.4 - 0.9 
J 61.6 58.2 - 3.4 55.6 — 6.0 
M 67.4 65.7 - 1.7 
P 74.3 72.9 - 1.4 67.6 - 6.7 
S 81.3 81.9 + 0.6 75.3 - 6.0 
FF 73.8 69.3 - 4.5 
Q 68.7 63.0 - 5.7 64.5 - 4.2 61.8 - 6.9 
u 74.9 72.9 - 2.0 
0 77.3 68.2 - 9.1 80.0 + 2.7 66.6 -10.7 
T 65.5 63.9 - 1.6 
R 70.5 66.7 - 3.8 64.4 - 6.1 
X 76.8 70.3 - 6.3 74.2 - 2.6 69.3 - 7.5 
N 77.3 76.1 - 1.2 72.4 - 4.9 
Y 79.0 75.8 - 3.2 
W 76.0 69.5 - 6.5 
Z 79.6 75.5 - 4.1 73.9 - 5.7 
V 81.0 75.7 - 5.3 73.6 - 7.4 
AA 80.8 79.5 - 1.3 
C 81.9 86.7 + 5.0 80.4 - 1.3 
BB 91.5 89.0 - 2.5 
EE 87.6 96.2 + 8.6 87.1 - 0.5 
CC 76.5 70.7 - 5.8 
DD 78.6 72.7 - 5.9 71.7 - 6.9 
X 72.8 ± 71.9 + 68.4 ± 
SEM 1.38 1.66 1.45 
^ody weights (periods I, II, and III) were recorded during a fasting state on the blood 
collection days at the Student Health Services. 
^Lowest refers to the lowest body weight achieved (period IV) by each female during the 
entire Body Weight Management Program. These weights were recorded at Andrews House 
during the weekly breakfast weigh-in meetings. 
their recommended weights. Unfortunately, the remaining dieters will 
return to their pre-reduction weights, and some will exceed their 
initial levels. 
At the onset of the study, the participants were enthusiastic and 
highly motivated to lose weight. Most of the participants had tried 
other weight reduction programs, such as Weight Watchers or some faddish 
dietary regimen. Their earlier attempts to lose weight and most 
important, to maintain the weight loss, were unsuccessful. The students 
enrolled in the BWMP with the idea of 'alas, this one (program) might 
work.' They had, however, been warned against this type of attitude. 
The philosophy of the BWMP was based on weight reduction by moderate and 
sensible changes in dietary and lifestyle habits. It was repeatedly 
stressed that these modifications would need to be continued for a 
lifetime in order to maintain a desirable body weight. 
The lowest body weight achieved for most of the participants 
occurred before the Christmas school break in December. During this 
30-day break, these young women were encouraged to maintain their weight 
losses and not attempt further weight reduction. A mean body weight 
gain of about 2 kg (about 4.5 lb) occurred during the break which was 
fairly encouraging. The body weight changes, however, ranged from 0.0 
kg to +9.6 kg (21.14 lb). 
After the holiday break, further weight loss was not achieved by 
the majority of the females. In fact, most of the body weights returned 
to the pre-reduction levels (Table A-5). In three cases (Subjects E, G, 
and EE), the final weights exceeded the pre-reduction body weight by at 
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least 5.0 kg (11 lb) (Table A-5, Change I-III column). 
Despite attempts to motivate the participants, many of the females 
lost their drive to lose weight after the first couple of months in the 
program. Several women requested that daily exercise classes be 
initiated into the program. Some of the participants took advantage of 
these free classes under the direction of the present researcher. Most 
of the women, however, found excuses for not participating; these same 
individuals were the ones who had requested that a scheduled exercise 
class be incorporated into the program. Not only were the participants 
to modify dietary intakes, but the BWMP encouraged them to adopt a daily 
exercise activity pattern. As mentioned previously, no charges were 
incurred by the participants in the BWMP. All of the services including 
dietary guidance on an individual and a group basis, weekly breakfast 
weigh-in meetings, daily computerized menus, and exercise classes were 
free-of-charge for the females. 
Generally, the lighter-weight-females were more difficult to 
motivate than the heavier participants. This observation is in 
agreement with an evaluation conducted by Seaton and Rose (12). They 
found that the frequency of defaulters from weight reduction clinics was 
greater among the lighter-weight individuals compared to the heavier 
subjects. 
The body weight changes for Subject 0 (relative body weight of 
129%) were particularly disappointing (Figure A-1). During the 13 weeks 
prior to Christmas break, this female lost 10.4 kg (23.8 lb). This 
weight loss was achieved by the combination of a decreased energy intake 
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and an increased energy expediture. During the 30-day term break, she 
gained 9.6 kg (21.1 lb). She stated that she was making up for "lost 
time," although she did feel badly about the weight gain. At the end of 
the BWMP, she weighed 78.2 kg (172 lb), which was +0.8 kg (1.8 lb) more 
than her initial body weight. 
One objective of this research was to evaluate the effectiveness of 
a nutritionally sensible weight reduction program for young college 
women. On a group basis, weight loss did not appear to be a good 
criterion to use. A mean weight loss of only 0.9 kg was calculated for 
the entire group (n=21); final body weight changes ranged from -5.9 kg 
(13.0 lb) to +8.6 kg (18.9 lb) (Table A-5, Change I-III column). For 
the majority of the females, the weight loss was of short duration 
(September through December). These body weight losses ranged from 
-10.7 kg (23.5 lb) to -0.5 kg (1.1 lb). (Table A-5, Change I-IV 
column). 
The cyclic loss and regain of body weight has been popularly termed 
the 'yo-yo syndrome.' The mechanisms underlying the cyclic weight 
patterns are unknown (13). Granted, everyone can lose weight to varying 
degrees. What is the merit, however, of weight reduction without 
maintenance of the weight loss? The maintenance of a desirable weight 
level is achieved only by a continual modification of lifestyle habits 
(dietary and physical activity) throughout a lifetime. It should be 
mentioned, however, an irreversible increase of adipocyte number in some 
obese individuals might make it difficult to maintain weight loss (13). 
Most of the students had modified some aspect of their eating 
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FIGURE 5. Body weight pattern for Subject 0 (initial relative 
body weight of 129%) in the Body Weight Management 
Program 
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pattern during the BWMP. A questionnaire at the end of the study 
indicated that the most common modifications were the omission of (1) 
salad dressings, (2) fried foods, and (3) margarine on potatoes and 
vegetables. In addition, most of the participants learned to use a 
trade-off system for their dietary intake selections. In this sense, 
you cannot have your cake and beer(s) too. 
Techniques are not available that predict those individuals who 
will lose weight successfully in weight reduction program. In addition 
to caloric restriction with or without exercise, there are many 
different types of treatment for obesity. Some of these include total 
starvation, jaw wiring, behavior techniques, and surgical intervention. 
It is, however, not known which approach would be the best method for a 
specific individual. 
The body weight reduction results of the BWMP appear dismal on a 
group basis. About 30% of the females (Subjects L, J, R, V, Z, DD, Q, 
T, W, Z), however, did achieve a weight loss of about 4.0 kg or more 
(about 9 lb). Most notably was the weight loss of Subject DD, one of 
the most overweight females (relative body weight of 162%). She was one 
of the original participants in the BWMP pilot study and elected to 
continue in the experimental study phase. During this one-year period, 
she lost 11.1 kg (about 25 lb) (Figure A-2). This decrease in weight 
was certainly a rewarding result and served to justify the BWMP. 
Moreover, she has maintained this weight loss for about 6 months 
(personal communication, ISU). The maintenance of weight loss can be 
achieved by modification of lifestyle, such as regulation of both 
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dietary intake and physical activity. Only a few, however, are 
successful. 
In summary, this program illustrated realistic body weight loss 
patterns for females involved in a weight reduction program. The 
females who did achieve a weight loss and the maintenance of the loss 
made the BWMP a successful endeavor. More important, the participants 
realized the need for nutritionally sensible eating habits. 
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FIGURE 6. Body weight pattern for Subject DD (initial relative 
body weight of 162%) in the Body Weight Management 
Program 
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APPENDIX B. INFORMATION ON THE USE OF HUMAN 
SUBJECTS IN RESEARCH 
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INFORMATION ON THE USE OF HUMAN'SUBJECTS IN RESEARCH 
IOWA 6TATE UNIVERSITY 
(Please follow the accompanying Instructions for completing this form.) 
Title of project (please type): Body Weight Management Prngram fnr MnHpra«-p1y 
,Obese.Young Women . • 
( 2J I agree to provide the proper surveillance of this project to Insure that the rights 
and welfare of the human subjects are properly protected. Additions to or changes 
in procedures affecting the subjects after the project has been approved will be 
submitted to the committee for review. 
Barbara Struemoler lyx ('vo 
Typed Named or Principal Investigator Date Signature of PrincipalInvestigator 
106 MacKav Hall 294-7316 
Campus Address Campus Telephone 
Signatures of others (if any) Date Relationship to Principal Investigator 
(/~^r //. ^ rt k I/Ué/J-ET Major Professor 
© ATTACH an additional page(s) (A) describing your proposed research and (B) the subjects to be used, (C) Indicating any risks or discomforts to the subjects, and 
(D) covering any topics checked below. CHECK all boxes applicable. 
pn Medical clearance necessary before subjects can participate 
(xl Samples (blood, tissue, etc.) from subjects ^ 
n Administration of substances (foods, drugs, etc.) to subjects 
I I Physical exercise or conditioning for subjects Iw 
I I Deception of subjects ^ 
I I Subjects under 14 years of age and(or) Q Subjects 14-17 years of age 
I I Subjects in Institutions 
I i Research must be approved by another institution or agency 
r 5w ATTACH an example of the material to be used to obtain informed consent and CHECK 
which type will be used. 
Fx] Signed informed consent will be obtained. 
I  I  Modified informed consent w i l l  be obtained. 
©Month Day Year Anticipated date on which subjects will be first contacted: Marrh ?? igR? 
Anticipated date for last contact with subjects: Mav Iq igfl? 
(7y If Applicable: Anticipated date on which audio or visual tapes will be erased and(or) 
Identifiers will be removed from completed survey instruments: 
Month Day Year 
Signature of Head or Chairperson Date Department or Administrative Unit 
^ Food and Nutrition 
9.J q^isIonVof the University~Commftteë~ôn~thë"Ûsë'ôf"HÛmân'sûbJëcts'ïn'Rësëârchl 
O Project Approved Q Project not approved Q No action required 
George G. Karas 
Name of Committee Chairperson Date Signature of Committee Chairperson 
Rpv i s(»d 6/78 
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Year - I98I-83 
INFORMATION TO SUBJECTS 
IOWA AGRICULTURE AND HOME ECONOMICS EXPERIMENT STATION 
Project 2213: Metabolic Patterns of Obese Women 
Body Weight Management Program for Moderately 
Obese Young Women 
Objectives; The purposes of this study are: 
(a) to set-up and assess the effectiveness of a body weight 
management program in an I SU residence hall for 
moderately obese college females 
(b) to study the relationship of fasting ( 12 hours after 
food consumption) and postprandial (1 hour after food 
consumption) levels of plasma and serum prostaglandins 
and plasma insulin and glucose levels among the 
program participants. 
Principal Investigators: 
Barbara Struempler, program director; 
Pilar A. Garcia, project leader; 
Assisted by Kathy Morrison and Ruth Smith, Human Nutrition Research 
Staff and Food and Nutrition students (enrolled in practicum courses). 
Office Phones: MacKay Hall 34A 4-7316 
Andrews House 4-7336 
Department: Food and Nutrition, Human Nutrition Research 
Cooperation: Dr. Donald Hotchkiss, statistical consultant, Statistical Laboratory 
Dr. Katherine Schneider, Consultant on eating behavior, ISU Student 
Counseling Service 
Dr. L.Z. Furman, M.D., medical consultant, ISU Student Health 
Service 
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Description of the Body Weight Management Program Study 
I. Background: Current dietary guidelines for Americans emphasize the 
attainment and maintenance of desirable weight. Excess fat or obesity 
In many people is assoicated with Increased incidence of degenerative 
disease. Evidence suggest that for the obese, the best preventive 
measure against cardiovascular disease is weight reduction. Recent 
work has also suggested an imbalance in prostaglandin production in 
obesity which may further increase the risk of developing athero­
sclerosis and adult-onset diabetes in the obese individual. 
Prostaglandins are derivatives of essential fatty acids and they 
are important regulators of many biological processes such as blood 
pressure, smooth muscle contractility and blood clotting, it has 
been reported that prostaglandins negatively feedback in the 
glucose-induced insulin secretion in humans and that an obese 
individual may overproduce or be hypersensitive to prostaglandins. 
A study of this nature should increase our understanding of the 
role of the prostaglandins in the management of obesity and weight 
maintenance following weight loss. 
II. Subjects: Subjects participating in the body weight management 
program must meet the following criteria: (a) female, (b) 18-22 
years of age, (c) body weight of 120-150% relative weight, 
(d) good health except for moderate obesity, as evidenced by a 
physical examination at the University Student Health Service, 
(e) no record of use of oral contraceptives or other medications, 
such as aspirin which would confound research data, (e) resident 
of Maple-Willow-Larch (M-W-L) dormitory complex and will consume 
meals that are served in the M-W-L Food Service facility, (f) 
good academic standing to manage additional load imposed by the 
study. 
A pre-study physical examination will be given and the program will 
be under continuous medical supervision. 
III. Period of Study: 
PrelIminary Study; 
March - May 14, 1982 Observation Period and recruitment. 
May - August 1982 Recruitment continued; further work on methodology. 
The main objective of the preliminary study Is to monitor the feeding 
phase of the body weight management program. 
Ten moderately obese female volunteers will participate in the body 
weight management program. Anthropometric measurements and 
blood samples will not be obtained during this period. 
Experimental Study: September 1982-May 1983 
The feeding phase of the body weight management program will consist of a 
5-day orientation period, followed by a restricted caloric intake 
(approximately 1000 kcal/day deficit) period. The restricted dietary 
intakes will range from 1200-1700 kcal/day. It is hoped that enough 
subjects achieve relative weights equivalent to one-half of the 
initial value and can be monitored for approximately three 
during a weight maintenance period. The physical activity 
adopted during this period will be monitored. 
months 
pattern 
1. Dietary Regime: The participants In the program will 
continue to consume meals that are served in the Maple-
Willow-Larch Food Service facility throughout the study. 
During the weight reduction period, the calorie Intake of 
each subject will be adjusted to provide an approximate 
1000 kcal deficit per day. Following the weight reduction 
period, the calorie intake of each subject will be 
adjusted to permit weight maintenance. Food choices will 
be closely monitored to help participants achieve their 
desirable weight goals. 
During university holidays, term breaks, and/or weekends : 
when meals are not eaten at the M-W-L Food Service facility, 
the subjects will record dietary Intakes according to the 
Instructions provided by the Food and Nutrition research 
staff. 
2. Blood Prostaglandins (PG), insulin and Glucose: The blood 
samples (20 ml each time) will be drawn by a registered 
medical technologist at the Student Health Service under 
stringent aseptic conditions. 
Fasting (12 hours after food consumption) and postprandial 
(1 hour after food consumption) blood samples will be obtained 
five times during the study for PG, glucose, and Insulin 
analysis: (1) during the orientation period, (2) during 
the first week of caloric restriction, (3) at a relative 
weight of 125%, (If Initial relative weight Is 150%), 
(4) at a relative weight of 100tl0%, and again (5) three 
months after a relative weight of 100110%. Arrangements 
will be made to eat breakfast at the Student Health 
Service following the fasting blood sample collection. 
3. Skinfold Thickness and Anthropometric Measurements: These 
measurements will be taken concurrently with the blood 
samples at the Andrews House by a research staff member. 
Skinfold thickness estimates body fat because a large 
proportion of the fat In an adult body is located under 
the skin. A constant pressure skinfold caliper is used 
for measuring skinfold thickness. 
Anthropometric measurements include height, weight, other 
indices of body frame and musculature. Tools used: 
platform scale, upright board with metric scale, sliding 
caliper, stainless steel tape, dynamometer. 
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4. Resting Metabolism: This standard measurement will be 
taken during the orientation period at the Andrews House. 
Measurements of resting metabolism provide estimates of the 
amount of energy needed by the body in a resting state. The 
tests will be given about 3 hours before the evening meanl. 
5. Physical Activity: Each subject will be encouraged to choose 
and adopt a pattern of physical activity as part of her 
program. She will keep a record at specified time intervals. 
IV. Risks: Minimum risks are involved in the drawing of blood including 
possible hematoma formation (similar to a bruise) and infection. 
Blood will be drawn by a registered medical technologist at the 
Student Health Service under stringent aseptic conditions minimizing 
any chance of the above. Some minimal pain is involved in blood 
drawing but this should be no greater than for any other venipuncture 
(blood tests) you may have had in past medical work. If a 
prospective participant has ever fainted or experienced dizziness 
when blood was drawn she should not volunteer for this study. 
V. Benefits: A program participant will have the opportunity to lose 
weight at a moderate rate while consuming nutritious food chosen 
on an individual basis. The ability to lose weight while participating 
in the program should help establish an eating and activity 
pattern that will allow you to maintain the weight loss. Additionally, 
the changes in the prostaglandins, glucose and insulin levels during 
and following the weight reduction period will increase our under­
standing of the role of the prostaglandins in the management of energy 
balance. The participant will be given access to results from this 
study for your own information and benefit. 
Withdrawal from the study: A participant may withdraw from the study at any 
time of her own free will, without giving a reason, or in any open or 
subtle way, being coerced to remain on the study. 
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Procedures to Which you as a Subject in this Study Agree -- In addition to 
the conditions of participation implied or stated in the attached 
"Information to Subject" I specifically understand and agree to the following: 
1. To cooperate willingly, of my own free will, and with a realization of 
the importance of complete honesty in adherence to all instructions 
and requirements. 
2. To realize that my own personal safety, health and well-being is of the 
upper most importance to me, and to you, and that -we both expect this to 
supersede all aspects of the study, and that to protect me and for purpose 
of the study, disclosure of complete medical information to the Physician-
in-Charge or her/his associates is necessary. This information will be 
used by the investigators in the study with every effort made to prevent 
undue disclosure about me as an individual. 
3' If selected as a subject, I will make every effort to adhere to the 
dietary recommendations on selection of food service menu items provided 
by the research staff in the study. 
4. I will allow blood samples to be drawn by venipuncture from the arm, 
by a registered medical technician at the Student Health Service at 
five different occasions (20 ml each time) during the study. Each of 
the five occasions will consist of two blood drawings, a fasting and 
postprandial sample. 
5. I agree to avoid taking any hormonal preparation during the study; 
I will not take other medications especially aspirin unless I consult 
the program director and the Physician-in-Charge or her/his 
associates. Aspirin inhibits the synthesis of prostaglandins. 
6. During the study I agree to have any medical examinations which the 
Physician-in-Charge may deem prudent or necessary to avoid risk to me 
from participation in the study. 
7. In consenting to participate in this study I agree to have read the 
"Information to Subjects", understand its contents, and have had it 
contents explained to me orally. I agree to participate fully and of my 
own free will in this study as indicated by my signautre on this and the 
attached "Informed Consent" form. 
Signature Witness 
Date 
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INFORMED CONSENT 
I, , have been Informed orally 
and in writing of the purpose, benefits, and potential hazards of the 
research project entitled "Body Weight Management Program for Moderately 
Obese Young Women" which is under the guidance of Barbara Struempler, 
program director and Pilar A. Garcia, project leader. 
I volunteer of my own free will to participate fully in this project. 
I understand that I will be given further explanation of the project 
and of specific procedures, if I so desire. I also understand that I 
may terminate my participation in the project at any time and that I 
am not waiving my legal rights. 
I understand that my records will be treated in a confidential manner 
as medical records, and that I will be given access to my records 
during and at the end of this study, if I so desire. 
Signature 
Witness 
Date 
MEDICAL CLEARANCE STATEMENT 
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To: Dr. L.Z. Furman, Examining Physician 
Student Health Service 
Iowa State University 
Ames, Iowa 50011 
From: Barbara Struempler, Program Director 
Body Weight Management Program 
106 MacKay Hal 1 
Iowa State University 
Ames, Iowa 50011 
Date: 
We have initiated a body weight management program in an ISU residence hall as 
part of a research project on moderately obese college females. The feeding 
phase of the research project has been integrated into the program with the 
cooperation of the Maple-Willow-Larch (M-W-L) Food Service facility at ISU. 
Following an orientation period, each subject will adjust her calorie intake 
to provide an approximate 1000 kcal deficit per day. The restricted dietary 
intakes will range from 1200-1700 kcal per day. Subjects will remain on the 
restricted dietary intakes until desired body weight is achieved. 
Thereafter, the calorie intake of each subject will be adjusted to permit 
weight maintenance. The body weight management program, its purpose, and 
procedures to be used are described in the attached statement of Information 
to Subjects together with the Informed Consent. 
To participate in our metabolic study, the female student must meet the 
following criteria: (a) 18-22 years of age, (b) body weight of 120-150% 
relative weight, (c) good health, except for moderate obesity, as evidenced 
by a physical examination at the University Student Health Service, (d) no 
record of use of oral contraceptives or other medications which would 
confound research data, (e) resident of Mapie-WiI low-Larch and uses the 
M-W-L Food Service facility, (f) good academic standing to manage additional 
load imposed by the study. Individual will maintain their physical activity 
pattern during the study and participants will monitor their activities. 
meets the criteria given above except 
Name of student 
for (c) and she has been referred to you for the physical examination. 
Please give us your medical recommendation by completing the following: 
Please check: 
I have no reservation regarding this student's participation in your study. 
I have reservations regarding this student's participation in your study. 
My reservations are as follows: 
a. 
b. 
c. 
Sianature of Phvsician Date 
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Dissertation Research Proposal 
Barb Struempler 
March 1982 
Food and Nutrition Department 
Doctor of Philosophy 
Proposed Title: Blood concentrations of prostaglandins, insulin, 
and glucose in overweight college women in a body 
weight management, program 
Justification: The discovery of prostaglandins (PGs) has caused researchers to 
reevaluate neurological and metabolic aspects of many diseases. It is well 
documented that PGs play an important physiological role in the regulation of 
lipid mobilization from adipose tissue. Steinberg et al. (1) and Bergstr^ôm 
et al. (2) were the first to observe that PGE] reduced basal or hormone-
stimulated lipolysis in adipose tissue in vitro. It is generally accepted that 
PGs are involved in the maintenance of adipose tissue homeostasis by a negative 
feedback inhibition mechanism. In the normal, adipose cell, cyclic AMP formation 
(inducing lipolysis) and PG synthesis are in a finely balanced state. 
In obesity, PG synthesis is excessive causing a negative inhibition on the 
cyclic AMP system (reducing lipolysis) at one or more steps. Hence, the 
mobilization of triglycerides from adipose tissue is "tuned-off" and little, 
if any release of free fatty acids and glycerol is observed (3). 
The insulin-like activities of PGs and their influence on blood insulin and 
glucose levels in human need evaluation. The majority of the data involving 
PGs and insulin (excluding diabetes research) consists of studies in vitro of 
adipose tissue or islets in the presence of a PG and/or glucose media (4, 5). 
Studies in vivo involve mainly animals such as dogs (6, 7) and sheep(8). The 
results from these studies are conflicting due to the methodology, the species 
variability, the concentration of PGs and glucose used in the studies, and the 
determination of a specific PG series. Extrapolation of data from these 
studies for human application is difficult but does provide a useful baseline 
for PG research in obese humans. 
The purposes of this research are: (a) to establish and assess the effectiveness 
of a body weight management program in an I SU residence hall for moderately obese 
college females, (b) to study the relationship of fasting (12 hours after food 
consumption) and postprandial (1 hour after food consumption) levels of plasma 
and serum PGs (E^, E^, Thromboxane B_ and 6-keto-PGF la) and plasma insulin and 
glucose levels among the program participants. It has been reported that 
prostaglandins negatively feedback in the glucose-induced insulin secretion in 
humans and that an obese individual may overproduce and be hypersensitive to 
prostaglandins. Moreover, only 5-25% of individuals on long-term weight 
reduction maintain weight loss (9). The changes in the PGs, glucose and 
insulin levels during and following an approximate energy deficit of 1000 kcal/ 
day would increase our understanding of the role of the PGs in the management 
of obesity and weight maintenance. 
Plan of Study: The body weight management program will be initiated in an 
I SU residence hall. The feeding phase of the research project will be 
integrated into the program with the cooperation of the Maple-Willow-Larch 
(MWL) Food Service facility at ISU. 
(over) 
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Thirty overweight females , 18-22 years of age, will be recruited as subjects. 
The females will be students at I SU and free-living in the MWL dormitory 
complex. The subjects must consume their meals at the MWL Food Service 
facility. The subjects will be less or equal to 150% relative weight at the 
beginning of the study. The body mass index (Wt„ /Ht^ 1.5) will be used to 
assess body fat (10). 
The feeding phase of the research project will consist of an orientation period 
followed by a restricted caloric intake (approximately 1000 kcal/day deficit) 
period. The restricted dietary intakes will range from 1200-1700 kcal/day. It 
is hoped that enough subjects achieve relative weights equivalent to one-half of 
the initial value and can be monitored for approximately three months during a 
weight maintenance period. The physical activity pattern adopted during the 
period will be monitored. 
Fastinq and postprandial blood samples will be obtained five times (see attached 
sheet) during the study for PG, glucose, and insulin analysis: (1) during the 
orientation period, (2) during the first week of caloric restriction, (3) st a 
relative weight of 125%, (if initial relative weight is 150%), (4) at a 
relative weight of 100+10%, and again (5) three months after a relative weight 
of 100+10%. Anthropometric measurements (skinfold and girth) will be measured 
concurrently. 
Data on fasting and postprandial serum PCs and plasma insulin and glucose will be 
analyzed statistically with regard to the changes in body composition in terms 
of fat and lean body mass. 
Literature Cited 
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prostaglandins on hormone-induced mobilization of free fatty acids. 
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2. Bergstrom, S. and L.A. Carlson. (1965) Inhibitory action of prostaglandin 
Ej on the mobilization of free fatty acids and glycerol from human adipose 
tissue in vitro. Prostaglandins and related factors. Acta. Physiol. 
Scand. 63:195-196. 
3. Curtis-Prior, P.B. (1975) Prostaglandins and obesity. Lancet 1:897-899. 
4. Johnson, D.G., P. Stromberg, W.Y. Fujimoto, and R.M. Williams. (1972) 
Enhanced release of Insulin by prostaglandins in Isolated pancreatic 
islets. Diabetes (Suppl 1) 329. 
5. Rossini, A.A., J.B. Lee and T.F. Frawley. (1971) An unpredictable lack of 
effect of prostaglandins on Insulin release in Isolated rat Islet. 
Diabetes 20:374. 
6. Lefebvie, P.J. and A.S. Luyekx. (1973) Stimulation of insulin secretion 
after prostaglandin PGE, in the anesthetized dog. Blochem. Pharmacol. 22: 
1773-1779. ' 
7. Robertson, R.P. (1973) inhibition of insulin secretion by prostaglandin (PG)E. independent of hypotensive or alpha adrenergic effect. Diabetes (Suppl 1) 305. 
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Tentative Time Schedule of Activities; Blood Concentrations 
of prostaglandins, insulin and glucose in overweight 
college women in a body weight maintenance program 
Dates Activity Brief Description 
Mar. 15 - Aug., 1982 Preliminary Study A) Set-up mechanics for (1) recruitment, (2) a monitored feeding 
system in the residence dining hall (with obese volunteers, n=ll), 
and (3) monitoring activités of participants during study. 
B) Set-up analytic procedure for serum PCs and plasma insulin and 
glucose. 
Aug. 1982-Hay, 1983 
31.1982 Aug. 23 - Aug 
1982 
Aug. 30 - Dec. 
1982 
17 
Experimental Study 
1) Program Orientation 
Target sample size: 30 individuals. Criteria 
for participation (a) female, (b) 18-22 years 
of age, (c) body weight 120-150% relative 
weight, (d) consume meals at residence dining 
hall, and (e) free-1ivinq in I SU dormitory. 
2) Feeding Phase at Residence Dining Hall 
A) Medical examination at I SU Health Service facility and completion 
of forms (participant approval forms) 
B) Meetings at Andrews House with participants for (1) progress report 
on program activités, (2) discussion of study protocol, 
(3) Darticipant/staff interaction. 
O 
Ln 
Aug. 30 - A) Orientation periods (see attached sheet) 
Sept. II, 1982 
Sept. 12 - B) Restricted caloric intake (a deficit of approximately 1000 kcal/ 
Dec. 17, 1982 day) period (see attached sheet) 
Jan. - May I983 3) Weight Maintenance Period A) (see attached sheet) 
, , following Weight Reduction (because of staggered 
participation into 
program) 
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Collection of postprandial* and fasting blood samples* for PG, insulin 
and glucose analysis and anthropometric measurements** 
Blood Samples 
Anthropometric Measurements 
Blood Samples 
Blood Samples 
Anthropometric Measurements 
Blood Samples 
Anthropometric Measurements 
Orientation Period 
(Aug. 30 - Sep. 11, 1982) 
(Relative weight 120-150%) 
V 
Restricted Caloric Intake Period 
(duration varies depending on initial 
relative weight and rate of weight loss) 
(Sep. 12 - Dec. 17, 1982) 
V 
First week of caloric restriction 
V Relative weight of 125% (if initial 
relative weight is 150%) 
Relative weight of 100±10% 
Blood Samples ^ Weight Maintenance Period*** following 
Anthropometric Measurements ^ Weight Reduction 
(Jan. - May, 1983) 
(Relative weight of 100+11 
* Postprandial blood sample (1 hour after food consumption) 
Fasting blood sample (12 hours after food consumption) 
** Anthropometric measurements will be obtained on four different occasions; 
blood samples will be obtained on five different occasions. 
*** Subjects who regain body wt. will remain in the study for observation. 
AUGUST SEPTEMBER OCTOBER NOVEMBER DECEMBER 
S M T W T F S S M T W T F S S M T W T F S S M T W T F S S M T W T F S 
1 2 3 4 5 6 7 12 3 4 1 2 1 2 3 4 5 6 12 3 4 
8 9 10 n 12 13 14 5 6 7 8 9 10 11 3 4 5 6 7 8 9 7 8 9 10 11 12 13 5 6 7 8 9 10 11 
12 13 14 15 16(018 15 16 17 19 20 21 12 13 14 15 16 17 18 10 11 12 13 14 15 16 14 15 16 17 18 19 20 
22 23 24(^26 27 28 19 20 21 22 23 24 25 17 18 19 20 21 22 23 21 22 23 24 25 26 27 19 20 21 22 23 24 25 
29 30 31 26 27 28 29 30 25 26 27 28 29 30 28 29 30 26 27 28 29 30 31 
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APPENDIX C. GENERAL INSTRUCTIONS ON DIETARY INTAKES 
DURING THE BODY WEIGHT MANAGEMENT PROGRAM 
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GENERAL INSTRUCTIONS ON DIETARY INTAKES DURING 
THE BODY WEIGHT MANAGEMENT PROGRAM 
Staff members to be contacted for information regarding meals, snacks, and 
food service: 
Commonly eaten foods are categorized according to their nutritional 
value. You can easily plan your restricted dietary intake by dividing 
foods into five groups; 
1) Dairy (D) 
2) Meats (M) 
3) Fruits (F)/Vegetables (V): 
• Includes: Citrus Fruit (Fc)/Dark-green Vegetable (Vg) 
4) Cereals (C) 
5) Empty: 
Includes: Fats (F)/Oils (0)/Sugar (S)/Alcohol (A) 
When food choices are based on the five groups, you will be able to choose 
foods that decrease your caloric intake but provide adequate vitamins, minerals, 
and protein. 
The foundation diet of the five groups (as follows) consists of a 
recommended number of the servings for the first four food groups and speci­
fies a maximum number of servings for the last group (Empty). This diet 
provides approximately 1200 kcal (calories) and allows you to make food choices 
to fit your eating style. You should make an effort to follow the recommended 
number of servings on a daily basis; however, a weekly balance is more meaning­
ful than a daily balance. It is important to remember that with any dietary 
plan, a variety of food choices will help to provide a nutritious diet. 
Barb Struempler 
Andrews House 
294-7336 
292-9647 (Home): until 
Ruth Smith 
34A MacKay Hall 
294-7316 
9 P.M 
RATIONAL OF THE RESTRICTED DIETARY INTAKE 
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Food Group Recommended No. One Serving is Equivalent to: Important 
of Servings Nutrients 
Dairy (D) 2 1 8-oz. c. skim milk Calcium 
1 c. yogurt Riboflavin 
1 si. cheese Vitamin Bg 
1-1/2 c. ice cream or ice milk Vitamin 
2 c. cottage cheese 
Meat (M) 2- 2-3 oz. lean, cooked meat Protein 
2-3 oz. poultry Phosphorus 
2-3 oz. fish Vitamin Bg 
Vitamin 
1 oz. of meat is equal to: Vitmain A: 
(liver & 
1 egg 
egg yolks) 
1/2-3/4 c. cooked dry beans 
2 tbsp. peanut butter 
1/4-1/2 c. nuts 
1 si. of cheese 
Fruits (F) 2 Includes all fruits: Vitamin C 
(include one 1/2 c. cooked or juice 
Fc daily). 1 fresh fruit (apple, orange) 
1/2 med. grapefruit 
One serving must include a citrus 
fruit (Fc): Vitamin C 
oranges, grapefruit, melons, 
berries, and tomatoes 
Vegetables (V) 2 Includes all vegetables: Vitamin A 
(include one wedge of lettuce 
Vg 3-4 bowl of salad 
times/week). 
1 med. potato 
One serving must include deep- Vitamin A 
yellow or dark-green vegetables Riboflavin 
(Vg), 3-4 times a week: Folacin 
1/2 c. carrots Iron 
Sweet potatoes 
Greens 
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Food Group Recommended No. One Serving is Equivalent to; Important 
of Servings Nutrients 
Cereal (C) 4 Includes all products made with Thiamin (Bj^) 
whole grains or enriched flour or Niacin 
meal: Iron 
1 si. bread 
1/2-3/4 c. cooked cereal 
1 oz. ready-to-eat cereal 
1/2-3/4 c. cooked rice, macaroni, 
noodles, spaghetti 
5 saltine crackers 
2 graham crackers 
1 med. potato 
1 muffin or biscuit (2" dia.) 
1/3 c. peas or cooked-dried beans 
1/3 c. com 
Empty (E): 
Fats/Oils (0) 
Sugars (S) 
Alcohol (A) 
Max. of Includes foods like butter, mar-
4 for garine, mayonnaise and other 
total salad dressings and other salad 
group. dressings and other fats and oils. 
Serving size is difficult to define, 
but in general; 
1/2 tbsp, butter, margarine, vegetable 
oil to other fats 
1 level tbsp. salad dressing 
5 olives 
1 si. drained, crisp bacon 
Includes foods like candy, sugar, jams, 
jellies, syrups, sweet toppings, and 
other sweets; soft drinks and other 
highly sugared beverages. 
Serving size is difficult to define, but 
in general; 
1 tbsp. jams/jellies 
1 tbsp. syrups 
Includes beer, wine, and hard liquor. 
Cut down on or eliminate alcholic 
drinks. 
I l l  
PROCEDURE FOR THE DETERMINATION OF THE CALORIE-RESTRICTED DIETARY INTAKE 
The menus for the coming week will be distributed on either Tuesday or Thursday 
morning at the weigh-in and breakfast meeting (7:00 A.M.) at Andrews House, Recom­
mendations on food choices will be provided by the FN research staff, although 
your dietary intake may be selected from a wide variety of food service menu 
items. 
Before planning your dietary intake, let us examine a sample menu (attached). 
The food items have been calculated to reflect the serving portion used in the 
M-W-L Food Service facility and its corresponding caloric (kcal) value. The main 
entree has been subdivided to reflect the ingredients of the item whenever possible. 
This should allow you enough flexibility to omit and combine foods as you wish. 
The food and menu items have been assigned a code number. The code number allows 
the research staff to identify the items. The food group letters correspond to 
the food groups which have been previously defined. 
The procedure for planning your dietary intake is simple and will be easy to 
use once you have become accustomed to the system. The following day's dietary 
intake should be planned (anticipated intake) the previous day. For example, anti­
cipate and plan Wednesday's dietary intake on Tuesday. The following steps should 
be used in planning and calculating the dietary intake: 
Step 1: Review the daily menu. 
Step 2: Select the food/main entree items that you prefer to eat and 
annotate the food group(s) and the caloric (kcal) value of these foods in the 
•Planned Intake column. 
Step 3: Determine (by addition) the number of servings from each food 
group and the kcal that have been marked in the Planned Intake column. In 
many situations, the food/menu items consist of one or more food groups. For 
example: M/O = 1 serving of Meat aW 1 serving of Oil 
0 0  = 2  s e r v i n g s  o f  O i l  
M/O/C = 1 serving of Meat and 1 serving of Oil and 1 serving 
of Cereal 
'jM or *30= 1/2 serving of Meat or 1/2 serving of Dairy 
tM/00 = 1/2 serving of Meat 2 servings of Oil 
V/S = 1 serving of Vegetables and 1 serving of Sugar 
^ Fc = 1/2 serving of Citrus Fruit 
I 
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Step 4: Subtract the planned number of servings of each food 
group from the recommended number of servings. This provides you with the num­
ber of servings that are further required to meet the recommended number of 
servings for each group. 
Step 5: Review the menu items again and select food items that pro­
vide the additional number of servings from the food groups and annotate the food 
groups and kcal in the planned Intake column. 
Step 6: Total (by the addition of Steps 3 and 5) the number of serv­
ings from each food group and the kcal. Again, compare this amount with the 
recommended number of servings. When you need to select additional foods to 
fulfill the recommended number of servings, repeat Steps 5 and 6. Your 
planned caloric intake should range from 1200 to 1700 kcal. Ifhen your planned 
caloric intake exceeds 1700 kcal, reselect menu items to decrease the caloric 
intake but still provide the recommended number of servings of the food groups. 
The easiest method to decrease the caloric intake is to select a main entree that 
has less calories than your previous (first) choice. 
Step 7: Immediately following the consumption of a snack or meal, 
circle the food group letter in the Food Group column and annotate the caloric value 
in the Actual Intake column. At the end of the day, annotate the total number of 
servings from the food groups and the total caloric intake in the boxes located at 
the bottom of the menu. Space is provided on the menu to describe any serving 
difficulties and for other comments. 
Food Substitutions by Food Service; Occasionally, a food item that appears 
on the menu will be replaced/substituted with another food item. When you consume 
the substituted food item, cross out the original food item and enter the actual 
(substituted) food item consumed below the original food item. Food substitutions 
will usually be of comparable food groups and caloric value. Therefore, add the 
food group(s) and the caloric value of the original food item into your total • 
dietary intake. Food substitutions will be less of a oroblem as vou become more 
familiar with che menu items. 
Salad Bar Selection: A list of Salad Bar Food Items has been given to you. 
You should check the food group and caloric value of a salad bar item before its 
consumption. The salad bar food items from Table A can be consumed in generous 
amounts, whereas, those foods from Table B should be eaten in limited amounts. 
The salad bar food items from Table C should not be consumed. As a general rule. 
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a tossed salad that consists of generous amounts of food items from Table A, 
such as lettuce, cabbage, carrots, celery, mushrooms, onions and tomatoes, will 
have approximately 50 kcal and provide one serving from the Vegetable group. 
When you prepare a tossed salad similar to the above from food items listed in 
Table A only, simply write "tossed salad from Table A, V (indicates the food group) 
and 50 kcal" in the space provided under Salad Bar on the menus. However, 
accurately indicate the code number, menu item, serving size, food group(s) and 
caloric value for a menu item from Table B. 
The low-calorie tossed salad will be a great source of calories when heaped 
with salad dressing. One level tablespoon of salad dressing has about 50 kcal and 
is one serving from the Fat/Oil group. As you realize, we seldom use this amount 
of dressing,on a tossed salad. Try to learn to like vinegar on your tossed salad. 
Another option to the high-calorie salad dressing is to purchase a low-calorie 
salad dressing from the grocer and bring the bottle with you to the dining hall. 
Condiments : A list of condiments available in the food service can be found 
following Table C in the Salad Bar Food Items list. Condiments that are added to 
a hamburger or other menu items contribute "empty" calories to the food item. In 
general, avoid mayonnaise, catsup, and sweet pickles/relish. 
Sauces/Gravies/Breadins; These items contribute "hidden" calories to the 
diet and should be omitted. Several meat items on the menu are breaded, then cooked, 
and you will be served the breaded portion of meat. However, the food group(s) and 
caloric value of the breaded items have been calculated without the breading. You 
must remove the breading from these meat items. The menus will usually specify 
that the breading should be removed, but if in doubt, always remove the breading. 
Snacks : Several food items available from the food service can be used as 
snacks and provide a serving from a food group (see list). A space for snack items 
is provided on the menu. You will need to annotate the code number, menu item 
(snack), serving size, food group(s) and caloric value on the menu. On occasion, a 
bag of popcorn will be provided to you by the research staff. 
Beverages ; Skim milk has essentially the same nutrients as whole milk but 
fewer calories. You must omit whole or 2% milks from your diet and drink skim milk. 
Fruit drinks (Hi-C, Tang) are not substitutes for fruit juices and should not be 
consumed. Coffee and tea (without sugar) may be consumed as desired. 
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Alcohol; Alcohol consumption is permitted during the restricted dietary 
intake period but in moderation only. Alcohol has approximately twice the calories 
per ounce as protein, starches, or sugars. Regardless of the type of alcohol, 
assume that a 12 ounce beer, or 1/2 cup of wine, or one jigger of hard liquor has 
130 kcal and is equivalent to one serving from the Alcohol group. Ifhen hard 
liquor is mixed with 6 ounces of a carbonated beverage (Cola, 7-Up), an additional 
70 kcal should be added to the 130 kcal from the hard liquor (200 kcal total per 
drink) and this is equivalent to one serving from the Alcohol group and one serving 
from the Sugar group. 
Sunday Night Dinners; Since this meal is not available from the food service, 
you will be entirely responsible for the selection of food items. But beware, this 
meal could drastically increase your caloric intake. It is always fun for "the group" 
to go out on Sunday nights for the thick, cheesy pizza (about 600 kcal per slice) or 
the Big Mac Attack (about 600 kcal per serving). Moreover, your caloric intake from 
the Sunday lunch may be greater than for other lunches or dinners due to the larger 
portion sizes and the limited food choices. You have been careful to restrict your 
caloric intake for the entire week, so why blow it now?? Regardless of your food 
choices for this meal, you must record the food items in the space provided under 
Dinner on the Sunday menu. Attempt to annotate the code numbers, menu items, serv­
ings sizes, food groups and caloric intakes. Most information is available from the 
daily menus. 
Two suggestions for low-calorie ideas for the Sunday night dinner are: 
1) A group of participants in the Body Weight Management Program can 
pool their funds and purchase containers of yogurt or cottage cheese, packages of 
sliced cheese or luncheon meats, a loaf of bread, a box of saltine/graham crackers, 
fruits and vegetables, skim milk, or diet pop. This potluck meal could be eaten in 
a dormitory room, lounge, or at Andrews House providing prior arrangements have been 
made with the research staff. (Popcorn would be made available by the research staff. 
This would also be a good time to complete your weekly forms). 
2) Eat a chef's salad in a food establish. (Code the food items from 
the Salad Bar Food Items list). 
ACTUAL DETERtllNATION OF THE RESTRICTED DIETARY INTAKE FROM A SAMPLE MENU 
We will now plan and calculate a dietary intake from a sample menu (attached). 
Refer to Steps 1-7 as previously discussed. The steps are also outlined on the bot­
tom of your menu. 
Step 1; Review menu. 
Step 2; Decide on food choices and annotate the food group(s) and kcal 
in the Planned Intake column. 
I 
ïfs 
Food Choices: 
Windsor Chop (dinner) 
Rice (dinner) 
Chicken Noodle Soup (lunch) 
Fresh Fruit Plate w/Amer. Cheese (lunch) 
Tossed Salad from Table A (lunch) 
Skim Milk (lunch - 8 oz.) 
Orange Juice (breakfast) 
1 Fried Egg (breakfast) 
1 si. English Muffin (breakfast) 
1 tbsp. Jam (breakfast) 
Step 3: Add the number of servings from each food group and kcal marked 
in the Planned Intake, column. 
Step 4 : Subtract the planned number of food groups from the recom­
mended number of servings. The recommended number of servings for each food group 
is located directly above the boxes at the end of the menu. 
Step 5: Review the menu items again and select foods to complete the 
recommended number of servings for each food group and annotate the food group(s) 
and kcal in the Planned Intake column. 
Food Choices; 
1 si. Bread (lunch) — See "Other Additions to Menu" on menu 
1/2 c. Skim Milk (dinner) 
Tossed Salad from Table A (dinner) 
5 Saltine Crackers (snack) 
1 Apple (snack) 
Step 6: Add together the number of servings from each food group and 
kcal (Steps 3 and 5). 
Step 7: At the end of the day, annotate the total number of servings and 
kcal in the boxes located at the bottom of the menu. 
Based on the sample menu, the recommended number of servings for each food group 
was met, except for one-half of a portion of Meat and one Green-Vegetable. These 
groups may be used in another day's dietary intake. Remember, a weekly balance is 
more important than a daily balance. 
116 
The planned and actual dietary intakes from t'ne sample menu illustrate 
how different foods can be combined to supply a nutritious low-calorie diet. The 
following menu can be constructed from the actual dietary intake from the sample 
menu. 
Breakfast Lunch Dinner 
5 oz. Orange Juice 
1 Fried Egg 
1/2 English Muffin 
1 tbsp. Jam 
Coffee/Tea 
4 oz. Chicken Noodle Soup 
Fresh Fruit Plate w/Amer. Cheese 
1 si. Bread 
Tossed Green Salad 
8 oz. Skim Milk 
Coffee/Tea 
3 oz. Windsor Chop 
1/4 c. White Rice 
Tossed Green Salad 
4 oz. Skim Milk 
Coffee/Tea 
Snacks 
Fresh Apple, 1 med. 
5 Saltine Crackers 
DISTRIBUTION AND PORTION CONTROL OF MENU ITEMS 
You will continue to eat your meals at the M-W-L- dining hall and use your meal 
ticket in the usual manner. 
The caloric values of the food items on the menus are based on normal portions 
served in ihe food service. Most menu items are served as a standardized portion, 
such as meats, soups, whipped potatoes, fruit .juices, rice, vegetables and scrambled eggs .  
Some menu items are not served as a standardized (nonstandardized) portion, such as 
salad bar items. 
You will be responsible for the serving of menu items from the salad bar. In 
general, one heaped tablespoon and one level tablespoon will provide 1/4 cup of Salad 
Bar items from Table B. 
Tongs will bo used to serve the shredded lettuce, cabbage, (Table A food items), 
but as previously emphasized, one cup of lettuce when compared to three cups nf lecture 
will not greatly affect your overall caloric intake. 
Immediately following a snack or meal, you should circle the appropriate food 
group and indicate the caloric value of the food in the Actual Intake column. Left­
overs should be subtracted from the actual serving portion. 
RESPONSIBILITIES OF THE PARTICIPANT IN THE BODY WEIGHT MANAGEMENT PROGRAM 
I. Food Selection 
You will be responsible for the selection of food items from the menus 
based on the five food groups. Your food choices should be varied to: (1) provide 
the essential nutrients; and (2) prevent a monotonous dietary regime. 
II. Maintenance of Records 117 
You will be responsible for the maintenance of several records which 
include: 
(1) the anticipated daily dietary intake: This involves a preliminary 
examination of the menus and selection of an anticipated dietary intake based on: 
(a) the five food groups, and (b) the menu items available from the food service. 
(2) the actual daily dietary intake: This requires that you appro­
priately annotate your actual intake on the menus immediately following its consump­
tion. At the end of the day, total your actual consumption and complete the infor­
mation on the menus. The completed menus for seven days are to be submitted to the 
research staff during the breakfast meetings on Monday at Andrews House. 
(3) the weekly dietary summary worksheet: This involves the composi­
tion of the weekly number of servings from each food group and a calculated weekly 
average caloric intake. The description and directions are provided on the worksheet. 
The worksheet is to be submitted with the completed daily menus to the research staff 
during the breakfast meetings at Andrews House. 
(4) the dietary intakes during University holidays, term breaks, 
and/or weekends: When meals are not eaten at the M-W-L dining facility, you will 
record your dietary intakes according to the instructions provided by the research 
staff. 
(5) the physical activity record (see below). 
Ill- Adoption of a Physical Activity Pattern 
In addition to decreasing your caloric intake, you should increase your 
energy expenditure. Your exercise regime does not need to be a strenous activity 
such as jogging. A brisk walk on a daily basis will "burn-off" the calories and 
"tone-up" the muscles. You will be encouraged to adopt an exercise pattern of your 
choice and keep a record of this activity. The description and directions 
are provided on the Physical Activity Pattern Chart. The chart is to be submitted 
with the completed daily menus and dietary summary worksheet to the resoa::c'' 
staff during the breakfast meetings at Andrews House. 
IV. Compliance with the Body Weight Management Program 
You should make an effort to comply with the dietary recommendations of 
the research staff. It is also important that you are honest with yourself in re­
cording your actual daily intake. Do not become a "closet muncher." The research 
staff realize that tliero are certain foods that you like that are not considered 
nutritious, low-calorie foods. However, it is important that you inform the staff 
of these foods, so that your intakes can be modified to allow for these foods (on a 
limited basis). The research staff is here to assist and guide you in losing weight 
and the maintenance of the weight loss. 
I 
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Salad Bar Food Items 
Table A 
Many food items are available from the salad bar in any amount that you wish. 
They contain few calories, provide roughage to the diet and supply many essential 
nutrients. 
Code No. Food Item 
486 
619 
Broccoli 
Carrots: 
fresh 
Amount 
1/2 c. (25 kcal) 
Strip 1/4" wide, 3" long 
Food Group 
Vg 
(5 strip = 10 kcal) 
622 canned 1/2 c. = 25 kcal V 
632 Cauliflower 1/2 c. = 15 kcal V 
637 Celery 3 stalks, 5" long, 3/4" wide 
= 10 kcal 
V 
942 Cucumbers 5 slices, 1/8" thick = 5 kcal V 
1415 Green Onions 1/4 c., chopped = 10 kcal V 
1545 Green Peppers 1/4 c., sliced = 5 kcal V 
1354 Mushrooms 1/2 0.. = 10 kcal V 
1258 Lettuce 1 c. shredded = 10 kcal V 
1412 Onions 1/4 c., chopped = 15 kcal V 
1844 Radishes 5 med. = 5 kcal V 
512 Red Cabbage 1 c., shredded = 20 kcal V 
1977 Sauerkraut 1/2 c. =20 kcal V 
2177 Spinach 1/2 c. = 25 kcal Vg 
2282 Tomatoes 
Zucchini 
1 tomato = 20 kcal Fc 
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Table B 
Many food items are available from the salad bar that should not be consumed 
in large amounts. The fruits or vegetables in tlie menu items are nutritious but 
either they contain a lot of calories for a small serving portion, or they have been 
mixed with sugar or oil which would greatly increase the caloric value of the food. 
Code No. Food Item Amount Food Group 
1529 Peas 1/2 c. =55 kcal C 
856 Corn 1/2 c. = 70 kcal C 
4R Cucumbers/Onions 
Sweet/Sour 1/4 c. = 45 kcal hVlhS 
2R Potato Salad 1/4 c. = 135 kcal QQ/hC 
3R Kidney Bean Salad 1/4 c. = 100 kcal hP/hO/hC 
6R Pea Salad 1/4 c. = 110 kcal hV/hO/hC 
8R Tomato/Cucumber/ 
Onion Salad 1/4 c. = 25 kcal hV/hS 
9R Marinated Chinese 1/4 c. = 50 kcal hC/hS Salad 
lOR Macaroni Salad 1/4 c. = 96 kcal O/hC 
IIR Sprout-kraut 1/4 c. = 90 kcal hV/S 
12R 3-Bean Salad 1/4 c. = 190 kcal tc/s 
13R Creamy Coleslaw 1/4 c. = 35 kcal hV/0 
15R Sweet/Sour Beets 1/4 c. = 115 kcal hV/S 
16R Carrot-Raisin 
Salad 
1/4 c. = 70 kcal hv/o 
653 Cheese 1/4 c., shredded = 105 kcal 'sM or '^D 
14R Devilled Eggs 1/2 egg = 55 kcal hK/kO 
974 Egg 1/4 c., chopped = 55 kcal tM/SO 
461 Croutons 1/2 c. = 50 kcal ^iC/kO 
1507 Pear, canned 1/2 pear (no syrup) = 80 kcal hF/hS 
1483 Peach, canned 1/2 peach (no syrup) = 80 kcal hP/hs 
29 Applesauce 1/4 c. = 60 kcal hF/S 
2005 Luncheon Meats 1/8 c., cubed = 35 kcal hn/^iO 
2236 Sunflower Seeds 1 tsp. = 100 kcal 00 
132R 24-Hour Salad 1 serving = 90 kcal F/S 
1.33R Fruit Mixture 1/4 c. = 30 kcal F/S 
1499 Peanut Butler ] .leviil tbsp = 95 kcci] 'sM/0 
1381 Chow Mein Noodles l/4c. , = 55 kcal \C/0 
1408 Black Olives 5 olives = l/4c. sliced = 40 kcal 0 
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T_aji.le C 
There are only a couple of food Items available from the salad bar that should 
not be consumed at any time. These foods are "loaded" with calories and have little, 
if any, nutritional value; 
Baco-bits 
Onion Rings 
Jcllo 
Condiments 
Code No. 
1938 
1373 
1558 
1561 
1565 
2286 
2287 
Food Item 
Mayonnaise 
Mustard 
Pickles 
Dill 
Sweet 
Relish 
Catsup 
Taco Sauce 
Amount Food Group 
1 tbsp. = 100 kcal 00 
1 tsp. (pouch) = 5 kcal 
(sliced lengthwise, 1/3) = 5 kcal 
(2')" long, 3/4" dia.) = 25 kcal 1/2 S 
1 tbsp. = 25 kcal 1/2 S 
1 packet = 15 kcal 
1 tbsp./I packet = 15 kcal 1/2 S 
1 tbsp. = 16 kcal 
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Snack Items 
Many foods make excellent snacks and provide a serving portion from a food 
group. A list of recommended snack items is below. 
Code No. Snack Item Food Group 
1 fruit = 80 kcal F 
916 5 saltine crackers (2" sq.) = 10 kcal/ C 
cracker 
913 1 graham cracker (2';" long, 2" wide, 1/2C 
V" thick) = 55 kcal 
1814 30 pretzels (sticks, 3" long, 1/8" dia.) C 
= 75 kcal 
4 oz. (1/2 c.) fruit juice = 50 kcal Fc 
1846 2 level tbsp. raisins = 50 kcal F 
653 1 si. cheese = 80 kcal 1/2M or 1/2D 
974 1 hard boiled egg = jij ^M/%0 
1 box cold cereal %= 1.00 kcal C 
1654 3 c. popcorn (ntr-poppwl) = 150 kr.il c 
2481 1 c. calorie yogurt - 210 kcal D or M 
carrots (.any amount) 
celery (any amount) 
radishes (any amount) 
1655 Popcorn w/ oil 1 c. = 75 (3 & = 225 kcal) C & lîjO 
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Weak 
Coda 
No. 
Planned 
Intake 
Menu Item 
Subject No 
Food Actual 
Group Intake 
B 
a 
E 
A 
K 
F 
A 
S 
T 
2288 
2288 
1071 
27 
1433 go 
461 
461 
1317 
1149 
973 
973 
g.  ^
T So 
ô~es-
Chilled Fruit Juice 
1 serving, Tomato (30 kcal) 
1 serving, V-8 (30 kcal) 
1 serving. Grapefruit (60 kcal) 
1 serving, Apple (75 kcal) 
1 serving. Orange (80 kcal) 
Cereal 
1 box. Cold (100 kcal) 
4 oz., 1 ladle, Hot (100 kcal) 
Toast/English Muffin 
1 si (65 kcal) 
2 si (130 kcal) 
Margarine, 1 pat (35 kcal) 
Jelly/Jam, 1 tbsp. (SO kcal) 
Fried Eggs 
2 eggs (170 kcal) 
1 egg (85 kcal) 
Fc 
Fc 
Fc 
© 
JSSL 
'311 
19R 
1902 
1902 
370 
13c 6F Ho 
1420b ÔP. th 
141c far Ito 
653 j&û Xû 
Chicken Noodle Soup 
4 oz., 1 ladle (25 kcal) 
Hamburger on Bun 
1 whole bun (120 kcal) 
1/2 bun (GO kcal) 
2.3 oz., 1 cooked Hb (185 kcal) 
Fresh Fruit Plate w/Aiaer. Cheese 
1/2 apple (40 kcal) 
1/2 orange (40 kcal) 
1/2 banana (40 kcal) 
1/2 Other 
1 si. cheese (80 kcal) 
French Fried Potatoes 
(OMIT) 
____ Fruit F 
(80 kcal) 
Salad Bar 
V SO 3o<IUltd SaMad 'JoJjù A, 
1/2 Fc 
1/2 F . 
SM oriHo) 
.ML 
& 
J4Q_ 
32: 
So 
Ij „  Ll. Milk, skim 
1322 aO 4» 4 oz., (4 c.)(4S kcal) 
Ù ga 8 oz., (1 c.)(90 kcal) 
VP 
JlL. 
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Male 
Subject No. Jiirv 
Code Planned Manu Item Food Actual 
No. Intake Group Intake 
• Windsor Chop —\ ~ 
1716 M/O 3lO 3.0 oz., 1 cooked portion (310 kcal) (M/Q/ 5/0 
Beef Stroganoff 
79R 1/4 c., 1 ladle (70 kcal) M 
Rice  ^ . 
1872 g. 30 174 c., 1 scoop (70 kcal) (o) 90 
Peas 
1530 _ Ï72 c., 1 scoop (55 kcal) C 
Fruit 
"IBO kcal) F 
Mashed Squash 
87R 1 scoop (SO kcal) Vg 
Salad Bar 
V 30 ToamS MIouA A > Qy 
£2 
Other Additions to Kenu/Snacks/Alcohol 
Hlol t  US / (£ua^ ) » © —^ 
ef lb t 50 5 .aajUtnt CAOCÀt^ Caa.o<à.)  ^
/3c F iù / ^ 
step 1: 
Step 2: 
Step 3: 
Step 4: 
Step S: 
Step 6: 
Step 7: 
Meat 
(2) 
Procedure for Planning and Calculating the Dietary Intake 
Review menu. 
Totals: 
Subtract: 
F <{| 4 V / ^cifsuUiS 
Fc i.ii v« o 
& <2. & o o /& o 
Determine additional food choices and annotate food group and kcal in Flan.__ 
Int. column. 
o / /  
1 
o o o 
50,50^  
4 JL -2. A o 
Add steps 
3 & 5: 
Following snack/maal, circle food group letters and mark kcal in Act. Int. col. 
Daily Totals 
Cereal 
(4) 
Dairy 
(2) 
Vege. 
(1) 
Vege.-gr. 
(1) 
(3-4x/wk) 
Fruit 
(1) 
Fruit-C 
(X) 
Empty Kcal 
(max 4) 1200-1700 
E S  0  0  
Serving Dlfficultlee; 
Comments: 
• /JSO 
124 
BIBLIOGRAPHY 
1. Adams, C. F. 1975. Nutritive value of American foods. USDA 
Agricultural Handbook No. 456. Washington, DC. 
2. Hathaway, M. L., and E. D. Foard. 1960. Heights and weights of 
adults in the United States. U.S. Department of Agriculture Home 
Econ. Res. Rep. No. 10. 
3. Abraham, S., and C. L. Johnson. 1979. Overweight adults in the 
United States. U.S. Department of Health, Education, and 
Welfare, Public Health Services No. 51. 
4. Davidson, S., R. Passmore, J. F. Brock, and A. S. Truswell. 
1979. Human Nutrition and Dietetics. 7th ed. Churchill, 
Livingstone, N.Y. 
5. Ayers, W. M. 1958. Changing attitudes toward overweight and 
reducing. J. Am. Dietetic Assoc. 34:23-29. 
6. Talbot, J. M. 1979. Research needs in management of obesity in 
severe caloric reduction. Life Sciences Research Office, 
Federation of American Societies for Experimental Biology, 
Bethesda, MD. 
7. Drenick, E. J., H. Blahd, F. R. Singer, and M. Lederer. 1966. 
Body potassium content of obese subjects and potassium depletion 
during prolonged fasting. Am. J. Clin. Nutr. 18:278-285. 
8. Bray, G. A. 1976. Treatment of the obese patient: Use of diet 
and exercise. Pages 300-352 in L. H. Smith, ed. The Obese 
Patient. W. B. Saunders Co., Philadelphia, PA. 
9. Drenick, E. J., and D. Johnson. 1978. Weight reduction by 
fasting and semistarvation in morbid obesity: Long-term follow-
up. Int. J. Obesity 2:23-35. 
10. Wing, R. R., and R. W. Jeffery. 1979. Outpatient treatments of 
obesity; A comparison of methodology and clinical results. Int. 
J. Obesity 3:261-279. 
11. Food and Nutrition Board. National Research Council. 1980. 
Recommended dietary allowances. 9th ed. National Academy of 
Sciences, Washington, D.C. 
12. Seaton, D. A., and K. Rose. 1965. Defaulters from a weight 
reduction clinic. J. Chronic Dis. 18:1007-1011. 
125 
13. Vasselli, J. R., M. P. Cleary, and T. B. Van Itallie. 1983. 
Modem concepts of obesity. Nutr. Rev. 41:361-373. 
